Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Thoracic Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 846 articles:
HTML format



Single Articles


    September 2021
  1. ULLAH W, Zghouzi M, Ahmad B, Suleiman AM, et al
    Safety and efficacy of the polymer-free and polymer-coated drug-eluting stents in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Sep 12. doi: 10.1002/ccd.29953.
    PubMed     Abstract available


  2. BRIZIDO C, Madeira M, Brito J, Madeira S, et al
    Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29948.
    PubMed     Abstract available


  3. MEDRANDA GA, Rogers T, Ali SW, Zhang C, et al
    Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29943.
    PubMed     Abstract available


  4. BEERKENS FJ, Singh R, Cao D, Claessen BE, et al
    Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
    Catheter Cardiovasc Interv. 2021 Sep 3. doi: 10.1002/ccd.29935.
    PubMed     Abstract available


  5. TARANTINI G, Zuccarelli V
    Percutaneous coronary intervention versus coronary artery bypass graft surgery: The battle rages on.
    Catheter Cardiovasc Interv. 2021;98:434-435.
    PubMed    


  6. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed    


  7. TANG GHL, Dangas GD
    Coronary access after valve-in-valve transcatheter aortic valve replacement: Time for a prospective study?
    Catheter Cardiovasc Interv. 2021;98:605-606.
    PubMed    


    August 2021
  8. LICHAA H
    Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique.
    Catheter Cardiovasc Interv. 2021 Aug 31. doi: 10.1002/ccd.29940.
    PubMed     Abstract available


  9. SAITO A, Dai Z, Ono M, Kanie T, et al
    The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: A systematic review and meta-regression analysis.
    Catheter Cardiovasc Interv. 2021 Aug 22. doi: 10.1002/ccd.29922.
    PubMed     Abstract available


  10. CHANG CW, Wadia SK, Rastogi A, Stinis CT, et al
    A unique cause of coronary obstruction after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29919.
    PubMed     Abstract available


  11. AMGAI B, Patel N, Chakraborty S, Bandyopadhyay D, et al
    30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29918.
    PubMed     Abstract available


  12. YIN T, Zhong X, Tao L, Hu T, et al
    Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29931.
    PubMed     Abstract available


  13. CHOI CH, Cao K, Malaver D, Kincaid EH, et al
    Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29921.
    PubMed     Abstract available


  14. FUKUTOMI M, Hokken T, Wong I, Bieliauskas G, et al
    Prophylactic permanent pacemaker strategy in patients with right bundle branch block undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29914.
    PubMed     Abstract available


  15. BRIGUORI C, Scarpelli M
    The "locking and dragging" technique a facilitated crossover balloon occlusion technique for complex iliofemoral anatomy in transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29915.
    PubMed     Abstract available


  16. NONA P, Mahmood S, Lemor A, Qintar M, et al
    Incidence of acquired ventricular septal defect after transcatheter aortic valve replacement: A large single center experience.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29897.
    PubMed     Abstract available


  17. TARANTINI G, Cardaioli F
    Transcatheter aortic valve replacement and chronic kidney disease: Close friends or sworn enemies?
    Catheter Cardiovasc Interv. 2021;98:328-329.
    PubMed    


  18. SHROFF GR, Henry TD
    Percutaneous coronary intervention in end-stage kidney disease: Trapped between a rock and a hard place.
    Catheter Cardiovasc Interv. 2021;98:215-216.
    PubMed    


  19. GARCIA S, Stanberry L, Schmidt C, Sharkey S, et al
    Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
    Catheter Cardiovasc Interv. 2021;98:217-222.
    PubMed     Abstract available


    July 2021
  20. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    PubMed     Abstract available


  21. SCHUMACHER SP, Everaars H, Stuijfzand WJ, van Diemen PA, et al
    Viability and functional recovery after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 30. doi: 10.1002/ccd.29888.
    PubMed     Abstract available


  22. MARCUSOHN E, Zukermann R, Kerner A, Roguin A, et al
    Long-term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29870.
    PubMed     Abstract available


  23. GOITIA J, Phan DQ, Lee MS, Moore N, et al
    The role of neighborhood disadvantage in predicting mortality in patients after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29872.
    PubMed     Abstract available


  24. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 8. doi: 10.1002/ccd.29860.
    PubMed     Abstract available


  25. HERMILLER JB JR, Gunnarsson CL, Ryan MP, Moore KA, et al
    The need for future coronary access following surgical or transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29841.
    PubMed     Abstract available


  26. POSTALIAN A, Krajcer Z
    Transcatheter aortic valve replacement has not helped bridge the racial disparity gap.
    Catheter Cardiovasc Interv. 2021;98:157-158.
    PubMed    


  27. ELGENDY IY, Jneid H
    Worsening renal function after transcatheter aortic valve replacement: Infrequent but deleterious.
    Catheter Cardiovasc Interv. 2021;98:195-196.
    PubMed    


    June 2021
  28. ISOGAI T, Saad AM, Michihata N, Ahuja KR, et al
    Association of hospital procedural volume with incidence and outcomes of surgical bailout in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 29. doi: 10.1002/ccd.29847.
    PubMed     Abstract available


  29. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed     Abstract available


  30. SCHUKRAFT S, Arroyo D, Togni M, Goy JJ, et al
    Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29837.
    PubMed     Abstract available


  31. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study.
    Catheter Cardiovasc Interv. 2021 Jun 19. doi: 10.1002/ccd.29842.
    PubMed     Abstract available


  32. AL-KASSOU B, Shamekhi J, Weber M, Germeroth J, et al
    Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 18. doi: 10.1002/ccd.29821.
    PubMed     Abstract available


  33. ENG MH, Kargoli F, Wang DD, Frisoli TM, et al
    Short- and mid-term outcomes in percutaneous mitral valve replacement using balloon expandable valves.
    Catheter Cardiovasc Interv. 2021 Jun 9. doi: 10.1002/ccd.29783.
    PubMed     Abstract available


  34. MAIER O, Piayda K, Afzal S, Polzin A, et al
    Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29805.
    PubMed     Abstract available


  35. SCHOECHLIN S, Schulz U, Ruile P, Hein M, et al
    Impact of high-sensitivity cardiac troponin T on survival and rehospitalization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29781.
    PubMed     Abstract available


  36. NICOLAS J, Mehran R
    Access routes in transcatheter aortic valve replacement: All roads lead to Rome but only one is paved.
    Catheter Cardiovasc Interv. 2021;97:1470-1471.
    PubMed    


  37. REILLY JP, Parikh PB
    Transcarotid transcatheter aortic valve replacement: The best alternative?
    Catheter Cardiovasc Interv. 2021;97:1460-1461.
    PubMed    


  38. RAHMAN F, Jneid H
    The continuing promise of the radial access for coronary interventions.
    Catheter Cardiovasc Interv. 2021;97:1397-1398.
    PubMed    


  39. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    PubMed     Abstract available


    May 2021
  40. LEE KH, Torii S, Oguri M, Miyaji T, et al
    Reduction of door-to-balloon time in patients with ST-elevation myocardial infarction by single-catheter primary percutaneous coronary intervention method.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29797.
    PubMed     Abstract available


  41. EL-SABAWI B, Guerrero ME, Eleid MF, Nkomo VT, et al
    Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: Incidence, patient characteristics, and clinical outcomes.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29779.
    PubMed     Abstract available


  42. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed     Abstract available


  43. O'NEILL BP, Grines C, Moses JW, Ohman EM, et al
    Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29758.
    PubMed     Abstract available


  44. JENTZER JC, van Diepen S, Henry TD, Baran DA, et al
    Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021 May 28. doi: 10.1002/ccd.29800.
    PubMed     Abstract available


  45. ROMEO FJ, Chiabrando JG, Seropian IM, Raleigh JV, et al
    Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 27. doi: 10.1002/ccd.29799.
    PubMed     Abstract available


  46. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed     Abstract available


  47. ELIA E, Iannaccone M, D'Ascenzo F, Gallone G, et al
    Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 May 24. doi: 10.1002/ccd.29757.
    PubMed     Abstract available


  48. MCGRATH DP, Kawabori M, Wessler B, Chen FY, et al
    A meta-analysis of transcarotid versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 12. doi: 10.1002/ccd.29768.
    PubMed     Abstract available


  49. SHOAIB A, Mohamed M, Curzen N, Ludman P, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29691.
    PubMed     Abstract available


    April 2021
  50. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed     Abstract available


  51. OBA Y, Inohara T, Takahashi M, Fukutomi M, et al
    In-hospital outcomes and usage of embolic protection devices in percutaneous coronary intervention for coronary artery bypass grafts: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2021 Apr 16. doi: 10.1002/ccd.29695.
    PubMed     Abstract available


  52. KIM M, Park KW, Lee HS, Ki YJ, et al
    The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29682.
    PubMed     Abstract available


  53. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed     Abstract available


  54. ASHLEY KE, Hillegass WB
    Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Catheter Cardiovasc Interv. 2021;97:795-796.
    PubMed    


  55. MORENO R, Diez JL, Diarte JA, Macaya F, et al
    Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak.
    Catheter Cardiovasc Interv. 2021;97:927-937.
    PubMed     Abstract available


  56. MAHTTA D, Jneid H
    Paravalvular leak after TAVR: remarkable improvement but not the time to shift focus.
    Catheter Cardiovasc Interv. 2021;97:903-904.
    PubMed    


  57. MUSUMECI G, Colopi M
    Coronary arterial disease in patients undergoing percutaneous edge-to-edge mitral valve repair: Handle with care.
    Catheter Cardiovasc Interv. 2021;97:925-926.
    PubMed    


  58. FARHAD H, Levy MS
    PCI for left main bifurcation stenting: A treatment paradigm at a crossroads?
    Catheter Cardiovasc Interv. 2021;97:786-787.
    PubMed    


  59. LANDES U, Kornowski R
    Same day discharge: How much less is more for TAVR patients?
    Catheter Cardiovasc Interv. 2021;97:948-949.
    PubMed    


  60. KAPLAN AV
    Left atrial appendage closure: Moving toward a same day standard.
    Catheter Cardiovasc Interv. 2021;97:917-918.
    PubMed    


    March 2021
  61. LIU ZY, Yin ZH, Liang CY, He J, et al
    Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29655.
    PubMed     Abstract available


  62. HU X, Qiao S, Guan C, Guo C, et al
    Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29651.
    PubMed     Abstract available


  63. SHAH AM, Siddiqui E, Cuenca C, Drotar P, et al
    Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29649.
    PubMed     Abstract available


  64. OTSUKA T, Ueki Y, Kavaliauskaite R, Zanchin T, et al
    Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29650.
    PubMed     Abstract available


  65. WANG H, Wang HY, Yin D, Feng L, et al
    Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29653.
    PubMed     Abstract available


  66. GAO L, Gao Z, Song Y, Guan C, et al
    Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29586.
    PubMed     Abstract available


  67. GRANOT Y, Merdler I, Finkelstein A, Arbel Y, et al
    Prognostic implication of right ventricular dysfunction and tricuspid regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Mar 7. doi: 10.1002/ccd.29639.
    PubMed     Abstract available


  68. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed     Abstract available


  69. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed     Abstract available


  70. ASHLEY KE, Hillegass WB
    Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment.
    Catheter Cardiovasc Interv. 2021;97:579-580.
    PubMed    


  71. LIU S, Song C, Yin D, Wang Y, et al
    Impact of public health emergency response to COVID-19 on management and outcome for NSTEMI patients in Beijing: A single-center historic control.
    Catheter Cardiovasc Interv. 2021;97:E475-E483.
    PubMed     Abstract available


  72. KONERU S, Jneid H
    Rescue valve-in-valve TAVI: Buy one get one free!
    Catheter Cardiovasc Interv. 2021;97:712-713.
    PubMed    


  73. ENG MH, Fang HK
    Transcarotid: A sign from above?
    Catheter Cardiovasc Interv. 2021;97:734-735.
    PubMed    


    February 2021
  74. SHARMA RK, Tuttle MK, Poulin MF, Laham RJ, et al
    CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29544.
    PubMed     Abstract available


  75. CAUGHRON H, Parikh D, Allison Z, Deuse T, et al
    Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29559.
    PubMed     Abstract available


  76. REILLY JP, Parikh PB
    PCI in TAVR patients: Timing isn't everything.
    Catheter Cardiovasc Interv. 2021;97:540-541.
    PubMed    


  77. KHOKHAR AA, Laricchia A, Ponticelli F, Kim WK, et al
    Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access.
    Catheter Cardiovasc Interv. 2021 Feb 14. doi: 10.1002/ccd.29503.
    PubMed     Abstract available


  78. THANDRA A, Abusnina W, Jhand A, Shaikh K, et al
    Valve-in-valve transcatheter aortic valve replacement versus redo surgical valve replacement for degenerated bioprosthetic aortic valve: An updated meta-analysis comparing midterm outcomes.
    Catheter Cardiovasc Interv. 2021 Feb 13. doi: 10.1002/ccd.29541.
    PubMed     Abstract available


  79. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    PubMed     Abstract available


  80. KIR D, Shapero K, Chatterjee S, Grimshaw A, et al
    Effect of institutional transcatheter aortic valve replacement volume on mortality: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29502.
    PubMed     Abstract available


  81. KINNAIRD T, Anderson R, Gallagher S, Sharp ASP, et al
    Vascular complications associated with intraaortic balloon pump supported percutaneous coronary intervention (PCI) and clinical outcomes from the British Cardiovascular Intervention Society National PCI Database.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29549.
    PubMed     Abstract available


  82. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.
    PubMed    


  83. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed     Abstract available


  84. YONG MS, Camuglia AC, Cox SV, Cole CM, et al
    Plaster pipes and crystalized graphite: Open transventricular transcatheter aortic valve replacement for failed mechanical aortic valve prostheses in the porcelain aorta.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29465.
    PubMed     Abstract available


  85. CHANGAL K
    Angiography versus fractional flow rate-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29540.
    PubMed    


  86. AL-HIJJI MA, ElHajj S, El Sabbagh A, Alkhouli MA, et al
    Temporal outcomes of transcatheter mitral valve replacement in native mitral valve disease with annular calcification.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29515.
    PubMed     Abstract available


  87. SHIELDS MC, Ouellette M, Kiefer N, Kohan L, et al
    Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29508.
    PubMed     Abstract available


  88. VAN WIECHEN MP, Kroon H, Hokken TW, Ooms JF, et al
    Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29506.
    PubMed     Abstract available


  89. ERINNE I, Sethi A, Johannesen J, Kassotis J, et al
    Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap?
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29487.
    PubMed     Abstract available


  90. PICCOLO R, Esposito G
    Percutaneous coronary intervention in patients with COVID-19 and acute coronary syndrome: What if the old normal became the new normal?
    Catheter Cardiovasc Interv. 2021;97:199-200.
    PubMed    


  91. AGARWAL SK, Uretsky BF
    Toward a more perfect coronary intervention....
    Catheter Cardiovasc Interv. 2021;97:245-246.
    PubMed    


  92. POSTALIAN A, Krajcer Z
    How often is urgent surgery required to address transcatheter mitral valve repair complications?
    Catheter Cardiovasc Interv. 2021;97:342-343.
    PubMed    


  93. MUSUMECI G, Annibali G
    Access site vascular complications in TAVR: Is this the right time?
    Catheter Cardiovasc Interv. 2021;97:333-334.
    PubMed    


  94. ENG MH, Verma DR
    Mitral valve-in-ring: Simply complicated.
    Catheter Cardiovasc Interv. 2021;97:359-360.
    PubMed    


  95. KERN MJ, Seto AH
    How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al.
    Catheter Cardiovasc Interv. 2021;97:257-258.
    PubMed     Abstract available


  96. BUTMAN SM
    Hybrid revascularization procedures for multivessel disease: 2021.
    Catheter Cardiovasc Interv. 2021;97:265-266.
    PubMed    


    January 2021
  97. SIMARD T, Alqahtani F, Hibbert B, Mamas MA, et al
    Sex-specific in-hospital outcomes of transcatheter aortic valve replacement with third generation transcatheter heart valves.
    Catheter Cardiovasc Interv. 2021 Jan 31. doi: 10.1002/ccd.29499.
    PubMed     Abstract available


  98. SAMMOUR Y, Kerrigan J, Banerjee K, Gajulapalli RD, et al
    Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience.
    Catheter Cardiovasc Interv. 2021 Jan 29. doi: 10.1002/ccd.29496.
    PubMed     Abstract available


  99. CHIARITO M, Cao D, Nicolas J, Roumeliotis A, et al
    Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021 Jan 28. doi: 10.1002/ccd.29486.
    PubMed     Abstract available


  100. ITO N, Zen K, Kuwabara K, Matoba S, et al
    Recapture failure in transcatheter aortic valve replacement with CoreValve Evolut R.
    Catheter Cardiovasc Interv. 2021 Jan 22. doi: 10.1002/ccd.29580.
    PubMed     Abstract available


  101. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    PubMed     Abstract available


  102. ELBADAWI A, Ugwu J, Elgendy IY, Megaly M, et al
    Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients.
    Catheter Cardiovasc Interv. 2021 Jan 5. doi: 10.1002/ccd.29426.
    PubMed     Abstract available


  103. KERN MJ
    Is stealing still a crime? Comment on left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021;97:105-107.
    PubMed     Abstract available


  104. FRANZONE A, Esposito G
    Clinical and hemodynamic performance of the ACURATE neo bioprosthesis: Looking far and beyond randomized trials.
    Catheter Cardiovasc Interv. 2021;97:175-176.
    PubMed    


  105. KRAJCER Z, Costello B
    Clinical impact of calcified nodules in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:20-21.
    PubMed     Abstract available


  106. MARMAGKIOLIS K, Cilingiroglu M
    TAVR in cancer; healing the sickest of the sick.
    Catheter Cardiovasc Interv. 2021;97:165-166.
    PubMed    


  107. CHUGH Y, Brilakis ES
    Intravascular lithotripsy for stent under-expansion: Panacea or Pandora's box?
    Catheter Cardiovasc Interv. 2021;97:30-31.
    PubMed     Abstract available


    December 2020
  108. PERDONCIN E, Greenbaum AB, Grubb KJ, Babaliaros VC, et al
    Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era.
    Catheter Cardiovasc Interv. 2020 Dec 31. doi: 10.1002/ccd.29453.
    PubMed     Abstract available


  109. PHAN DQ, Lee MS, Aharonian V, Mansukhani P, et al
    Association between mid-term worsening renal function and mortality after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29429.
    PubMed     Abstract available


  110. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    PubMed     Abstract available


  111. LECLERCQ F, Choteau R, Cayla G, Chamard C, et al
    Transcarotid versus transfemoral access in patients undergoing transcatheter aortic valve replacement with complex aortofemoral anatomy.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29438.
    PubMed     Abstract available


  112. BLOOM JE, Dinh DT, Noaman S, Martin C, et al
    Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29436.
    PubMed     Abstract available


  113. ASIF A, Sezer A, Thoma F, Toma C, et al
    Relationship between predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score and mortality among patients with atrial fibrillation undergoing percutaneous coronary interv
    Catheter Cardiovasc Interv. 2020 Dec 9. doi: 10.1002/ccd.29399.
    PubMed     Abstract available


  114. COCKBURN J, Kemp T, Ludman P, Kinnaird T, et al
    Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly.
    Catheter Cardiovasc Interv. 2020 Dec 6. doi: 10.1002/ccd.29406.
    PubMed     Abstract available


  115. LAZKANI M, Tripathi B, Dattilo P
    Impact of intracoronary imaging on in-hospital mortality and 30-day readmission rates following percutaneous coronary intervention: A nationwide readmissions database analysis.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29394.
    PubMed     Abstract available


  116. KRAJCER Z, Costello B
    Effect of concomitant aortic regurgitation on early hypoattenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020;96:1498-1499.
    PubMed     Abstract available


    November 2020
  117. BLUM M, Cao D, Chandiramani R, Goel R, et al
    Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29402.
    PubMed     Abstract available


  118. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    PubMed     Abstract available


  119. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    PubMed     Abstract available


  120. RZUCIDLO J, Jaspan V, Paone D, Jilaihawi H, et al
    Long-term outcomes after transcatheter aortic valve replacement with minimal contrast in chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29378.
    PubMed     Abstract available


  121. ARORA S, Lahewala S, Zuzek Z, Thakkar S, et al
    Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience.
    Catheter Cardiovasc Interv. 2020 Nov 9. doi: 10.1002/ccd.29379.
    PubMed     Abstract available


  122. CHIARITO M, Mehran R
    Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough?
    Catheter Cardiovasc Interv. 2020;96:1110-1112.
    PubMed    


  123. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  124. POSTALIAN A, Krajcer Z
    Chronic total occlusion percutaneous coronary intervention: The Latin American experience.
    Catheter Cardiovasc Interv. 2020;96:1056-1057.
    PubMed    


  125. SHAH S, Castro-Dominguez Y, Gupta T, Attaran R, et al
    Impact of the COVID-19 pandemic on interventional cardiology training in the United States.
    Catheter Cardiovasc Interv. 2020;96:997-1005.
    PubMed     Abstract available


  126. POSTALIAN A, Krajcer Z
    Preventing tricuspid valve injury during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2020;96:1294-1295.
    PubMed     Abstract available


    October 2020
  127. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed     Abstract available


  128. ALRAIES MC, Al-Khadra Y
    Heterogeneity of Impella use in the United States for high-risk coronary interventions.
    Catheter Cardiovasc Interv. 2020 Oct 24. doi: 10.1002/ccd.29346.
    PubMed    


  129. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    PubMed     Abstract available


  130. GOEL R, Cao D, Chandiramani R, Roumeliotis A, et al
    Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29314.
    PubMed     Abstract available


  131. SAMMOUR Y, Sato K, Kumar A, Gajulapalli RD, et al
    Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29309.
    PubMed     Abstract available


  132. MISUMIDA N, Guerrero M, Pislaru SV, Alkhouli M, et al
    Hemodynamic response to transseptal transcatheter mitral valve replacement in patients with severe mitral stenosis due to severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29285.
    PubMed     Abstract available


  133. DANGAS G, Khan AA
    Rolling the rock uphill during left main stenting: The Sisyphus myth in percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2020;96:762-763.
    PubMed    


  134. WHITESIDE HL, Moliterno DJ
    Coronary interventions among patients with hepatic insufficiency: Encouragement to avoid a jaundiced view.
    Catheter Cardiovasc Interv. 2020;96:811-812.
    PubMed    


  135. GRINES CL, Tummala P
    Another nail in the coffin for the use of risk-adjusted mortality after percutaneous coronary intervention as a quality indicator.
    Catheter Cardiovasc Interv. 2020;96:741-742.
    PubMed    


  136. OOI YS, Gray WA
    One in one equals two.
    Catheter Cardiovasc Interv. 2020;96:987-988.
    PubMed    


  137. COLOMBO A, Laricchia A
    Removing the plaque and implanting a drug-eluting stent: The way to success.
    Catheter Cardiovasc Interv. 2020;96:782-783.
    PubMed    


  138. TARANTINI G, Nai Fovino L
    TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more.
    Catheter Cardiovasc Interv. 2020;96:956-957.
    PubMed    


  139. ARANZULLA TC, Musumeci G
    Remove the obstacle and get into the flow!
    Catheter Cardiovasc Interv. 2020;96:979-980.
    PubMed    


    September 2020
  140. MORIYAMA N, Lehtola H, Miyashita H, Piuhola J, et al
    Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29281.
    PubMed     Abstract available


  141. PIRIOU PG, Bonin M, Huchet F, Letocart V, et al
    Standardized fractal bench test evaluation of coronary stents: Performances in bifurcation lesions treated by the re-proximal optimization technique.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29288.
    PubMed     Abstract available


  142. HASE H, Yoshijima N, Yanagisawa R, Tanaka M, et al
    Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29259.
    PubMed     Abstract available


  143. IMAMURA T
    How to prevent thrombosis following transcatheter aortic valve replacement during durable left ventricular assist device supports.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29268.
    PubMed    


  144. KUNO T, Takagi H, Ando T, Kodaira M, et al
    Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29236.
    PubMed     Abstract available


  145. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29234.
    PubMed     Abstract available


  146. SHARMA SP, Chaudhary R, Ghuneim A, Harder W, et al
    Carotid access for transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244.
    PubMed     Abstract available


  147. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2020 Sep 2. doi: 10.1002/ccd.29230.
    PubMed     Abstract available


  148. BENGALURU JAYANNA M, Gray WA
    Applied pharmacology in percutaneous coronary intervention: You can't fight mother nature.
    Catheter Cardiovasc Interv. 2020;96:565-566.
    PubMed     Abstract available


  149. SHAH PB, Welt FGP, Mahmud E, Phillips A, et al
    Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement.
    Catheter Cardiovasc Interv. 2020;96:659-663.
    PubMed     Abstract available


  150. ANUWATWORN A, Bailey SR
    Predicting who benefits from mitral valve percutaneous repair: It's not just the valve.
    Catheter Cardiovasc Interv. 2020;96:698.
    PubMed    


  151. TARANTINI G, Masiero G
    Early readmission after mitral valve repair: God is in the details.
    Catheter Cardiovasc Interv. 2020;96:675-677.
    PubMed    


  152. TANNOUS P, Popescu A, Forbess L, Nugent A, et al
    Transcatheter biventricular conversion in an adult patient with a 1.5 ventricle Glenn palliation and superior vena cava syndrome.
    Catheter Cardiovasc Interv. 2020;96:633-637.
    PubMed     Abstract available


  153. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  154. PULS M, Huenlich M, Boekstegers P, Lubos E, et al
    Implantation of one versus two MitraClips in the German TRAMI registry: Is more always better?
    Catheter Cardiovasc Interv. 2020;96:E360-E368.
    PubMed     Abstract available


  155. TOVAR FORERO MN, Van Mieghem NM, Daemen J
    Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
    Catheter Cardiovasc Interv. 2020;96:598-600.
    PubMed     Abstract available


  156. DE ROECK F, Tijskens M, Segers VFM
    Coronary-subclavian steal syndrome, an easily overlooked entity in interventional cardiology.
    Catheter Cardiovasc Interv. 2020;96:614-619.
    PubMed     Abstract available


  157. HUMMEL J, Kubicki R, Pingpoh C, Stiller B, et al
    Surgically placed radiopaque markers: Proof-of-concept of a novel technique to facilitate percutaneous interventions in neonates and infants.
    Catheter Cardiovasc Interv. 2020;96:E303-E309.
    PubMed     Abstract available


  158. NOAMAN S, Andrianopoulos N, Brennan AL, Dinh D, et al
    Outcomes of cardiogenic shock complicating acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020;96:E257-E267.
    PubMed     Abstract available


  159. PAL N, Jones D, Rice G, Sinhal A, et al
    Case report describing late balloon dilatation as a treatment for paravalvular leak with intuity elite rapid deployment valve.
    Catheter Cardiovasc Interv. 2020;96:E292-E294.
    PubMed     Abstract available


  160. HASEGAWA K, Yamamoto W, Nakabayashi S, Otsuji S, et al
    Streamlined reverse wire technique for the treatment of complex bifurcated lesions.
    Catheter Cardiovasc Interv. 2020;96:E287-E291.
    PubMed     Abstract available


  161. SATHANANTHAN J, Hensey M, Fraser R, Landes U, et al
    Implications of hydrodynamic testing to guide sizing of self-expanding transcatheter heart valves for valve-in-valve procedures.
    Catheter Cardiovasc Interv. 2020;96:E332-E340.
    PubMed     Abstract available


    August 2020
  162. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29247.
    PubMed     Abstract available


  163. RAGOSTA M, Boehm R, Shields M, Taylor AM, et al
    Intentional removal of erroneously deployed coronary stents: A case series and review of the literature.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29256.
    PubMed     Abstract available


  164. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29189.
    PubMed     Abstract available


  165. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    PubMed     Abstract available


  166. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Aug 14. doi: 10.1002/ccd.29176.
    PubMed     Abstract available


  167. SHAH H, Patel S, Solanki S, Wudexi I, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients undergoing percutaneous coronary intervention: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29184.
    PubMed     Abstract available


  168. SAGLIETTO A, D'Ascenzo F, Errigo D, Leonardi S, et al
    Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29192.
    PubMed     Abstract available


  169. KASSIS N, Saad AM, Ahuja KR, Gad MM, et al
    Impact of thoracic aortic aneurysm on outcomes of transcatheter aortic valve replacement: A nationwide cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29195.
    PubMed     Abstract available


  170. BIANCARI F, Pykari J, Savontaus M, Laine M, et al
    Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29177.
    PubMed     Abstract available


  171. LAFONT A, Sinnaeve PR, Cuisset T, Cook S, et al
    Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29159.
    PubMed     Abstract available


  172. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2020 Aug 5. doi: 10.1002/ccd.29158.
    PubMed     Abstract available


  173. TARANTINI G, Fabris T
    Minimalist transfemoral transcatheter aortic valve replacement: Make it as simple as possible, but not simpler.
    Catheter Cardiovasc Interv. 2020;96:471-472.
    PubMed     Abstract available


  174. ASHLEY KE, Hillegass WB
    Insulin-treated diabetes mellitus: An actionable risk factor and marker after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020;96:309-310.
    PubMed    


  175. OLIVEIRA FA, Lemos PA
    TAVR patients count on their thrombocytes: Platelets count is accountable for the outcomes!
    Catheter Cardiovasc Interv. 2020;96:422-423.
    PubMed     Abstract available


  176. MUSUMECI G, Albani S
    US-guided vascular access and left ventricular rapid pacing in TAVR: Two simple points that may improve patients' outcomes.
    Catheter Cardiovasc Interv. 2020;96:440-441.
    PubMed     Abstract available


  177. STABILE E, Esposito G
    A single stich is maybe enough.
    Catheter Cardiovasc Interv. 2020;96:448-449.
    PubMed     Abstract available


  178. BAYON J, Santas-Alvarez M, Ocaranza-Sanchez R, Gonzalez-Juanatey C, et al
    Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?
    Catheter Cardiovasc Interv. 2020;96:E174-E176.
    PubMed     Abstract available


  179. XI Y, Chen J, Bi Y, Xie S, et al
    Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Catheter Cardiovasc Interv. 2020;96:E129-E141.
    PubMed     Abstract available


  180. BRIGUORI C, Tamburino C, Jessurun GAJ, Meyer-Gessner M, et al
    Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study.
    Catheter Cardiovasc Interv. 2020;96:E142-E148.
    PubMed     Abstract available


  181. YAN C, Wan L, Li L, Li H, et al
    Transfemoral transcatheter puncture of interventricular septum in a swine model: A novel transfemoral-venous access to left ventricle with the assistance of arterio-venous circuit.
    Catheter Cardiovasc Interv. 2020;96:488-496.
    PubMed     Abstract available


  182. TAN W, Calfon Press M, Lluri G, Aboulhosn J, et al
    Percutaneous edge-to-edge repair for common atrioventricular valve regurgitation in a patient with heterotaxy syndrome, single ventricle physiology, and unbalanced atrioventricular septal defect.
    Catheter Cardiovasc Interv. 2020;96:384-388.
    PubMed     Abstract available


  183. SIVAKUMAR K, Anantharaj A, Raghuram P, Krishna Kumar R, et al
    First in man study of a new semi-open cell design Zephyr cobalt-chromium stent in large vessels and conduits.
    Catheter Cardiovasc Interv. 2020;96:367-375.
    PubMed     Abstract available


  184. LAUCK SB, Sathananthan J, Park J, Achtem L, et al
    Post-procedure protocol to facilitate next-day discharge: Results of the multidisciplinary, multimodality but minimalist TAVR study.
    Catheter Cardiovasc Interv. 2020;96:450-458.
    PubMed     Abstract available


    July 2020
  185. ADDIS DR, Law M, von Mering G, Ahmed M, et al
    Codeployment of a percutaneous edge-to-edge mitral valve repair device and a ventriculoseptal defect occluder device to address complex mitral regurgitation with leaflet perforation.
    Catheter Cardiovasc Interv. 2020 Jul 31. doi: 10.1002/ccd.29147.
    PubMed     Abstract available


  186. YAMAMOTO M, Otsuka T, Shimura T, Yamaguchi R, et al
    Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130.
    PubMed     Abstract available


  187. SHAH H, Ramineni G, Varghese R, Thwe EE, et al
    Outcomes of percutaneous coronary interventions in patients with liver transplant.
    Catheter Cardiovasc Interv. 2020 Jul 29. doi: 10.1002/ccd.29168.
    PubMed     Abstract available


  188. SIUDAK Z, Grygier M, Wojakowski W, Malinowski KP, et al
    Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2020 Jul 20. doi: 10.1002/ccd.29134.
    PubMed     Abstract available


  189. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2020 Jul 20. doi: 10.1002/ccd.29119.
    PubMed     Abstract available


  190. SHEIKH MA, Deo SV, Riaz H, Raza S, et al
    Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29123.
    PubMed     Abstract available


  191. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    PubMed     Abstract available


  192. ADAMO M, Provini M, Fiorina C, Giannini C, et al
    Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project.
    Catheter Cardiovasc Interv. 2020 Jul 9. doi: 10.1002/ccd.28927.
    PubMed     Abstract available


  193. KHAN MZ, Khan MU, Kalra A, Krupica T, et al
    Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease.
    Catheter Cardiovasc Interv. 2020 Jul 7. doi: 10.1002/ccd.29109.
    PubMed     Abstract available


  194. SATHANANTHAN J, Lauck S, Polderman J, Yu M, et al
    Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29124.
    PubMed     Abstract available


  195. FRACCARO C, Campante Teles R, Tchetche D, Saia F, et al
    Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29112.
    PubMed     Abstract available


  196. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    PubMed     Abstract available


  197. COSTA G, Ihlemann N, Sondergaard L, De Backer O, et al
    Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29108.
    PubMed     Abstract available


  198. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jul 3. doi: 10.1002/ccd.29122.
    PubMed    


  199. COSTA G, Bieliauskas G, Fukutomi M, Ihlemann N, et al
    Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.
    Catheter Cardiovasc Interv. 2020 Jul 1. doi: 10.1002/ccd.29117.
    PubMed     Abstract available


  200. GRINES CL, Cox D
    Can percutaneous coronary interventions be performed safely in leukemia patients?
    Catheter Cardiovasc Interv. 2020;96:64-65.
    PubMed     Abstract available


  201. SRIDHARAN A, Kimmelstiel C
    Morphine in primary percutaneous coronary intervention-No pain, questionable gain.
    Catheter Cardiovasc Interv. 2020;96:89-90.
    PubMed     Abstract available


  202. PARIKH PB, Reilly JP
    Women with chronic kidney disease undergoing transcatheter aortic valve replacement: Caveat emptor.
    Catheter Cardiovasc Interv. 2020;96:208-209.
    PubMed     Abstract available


  203. CHENEY A, Dean LS
    State-of-the-art percutaneous coronary interventions applied to the treatment of bifurcation lesions: Are we there yet?
    Catheter Cardiovasc Interv. 2020;96:18-19.
    PubMed     Abstract available


  204. TARANTINI G, Giacoppo D
    Transcatheter versus surgical aortic valve replacement in the digital era: Meta-analysis based on the reconstruction of time-to-event individual patient data.
    Catheter Cardiovasc Interv. 2020;96:167-168.
    PubMed     Abstract available


  205. KORNOWSKI R
    Appraisal of urgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;96:196-197.
    PubMed     Abstract available


  206. PICCOLO R, Esposito G
    Ticagrelor monotherapy in patients undergoing percutaneous coronary intervention for bifurcation lesions.
    Catheter Cardiovasc Interv. 2020;96:112-113.
    PubMed     Abstract available


  207. BUTMAN SM
    Revascularization for multivessel disease: Getting closer, but....
    Catheter Cardiovasc Interv. 2020;96:52.
    PubMed     Abstract available


  208. ARANZULLA TC, Musumeci G
    True caring is protecting who is at your side.
    Catheter Cardiovasc Interv. 2020;96:29-30.
    PubMed     Abstract available


  209. SHISHIDO K, Moriyama N, Hayashi T, Yokota S, et al
    The efficacy of modified jailed balloon technique for true bifurcation lesions.
    Catheter Cardiovasc Interv. 2020;96:20-28.
    PubMed     Abstract available


  210. ANDREASEN LN, Holm NR, Webber B, Ormiston JA, et al
    Critical aspects of balloon position during final proximal optimization technique (POT) in coronary bifurcation stenting.
    Catheter Cardiovasc Interv. 2020;96:31-39.
    PubMed     Abstract available


  211. LARICCHIA A, Mangieri A, Colombo A, Giannini F, et al
    Perceval sutureless valve migration treated by valve-in-valve with a CoreValve Evolut Pro.
    Catheter Cardiovasc Interv. 2020;96:225-227.
    PubMed     Abstract available


  212. KUMAR K, Reddy S, Acharya D, Lotun K, et al
    Novel technique of performing multivessel PCI through an Impella sheath.
    Catheter Cardiovasc Interv. 2020;96:117-120.
    PubMed     Abstract available


  213. AKKAYA E, Sozener K, Rixe J, Tsiakou M, et al
    Venous access closure using a purse-string suture without heparin antagonism or additional compression after MitraClip implantation.
    Catheter Cardiovasc Interv. 2020;96:179-186.
    PubMed     Abstract available


  214. STRIPE BR, Singh GD, Smith T, Rogers JH, et al
    Retrieval of a MitraClip from the left atrium using a two-snare technique: Case report and review of the literature.
    Catheter Cardiovasc Interv. 2020;96:210-214.
    PubMed     Abstract available


  215. LIU J, Li L, Chen C, Wei J, et al
    Modified kissing balloon inflation associated with better results after Culotte stenting for bifurcation lesions: A bench test.
    Catheter Cardiovasc Interv. 2020;96:E34-E44.
    PubMed     Abstract available


  216. KATSIKIS A, Keeble TR, Davies JR, Jagathesan R, et al
    Contemporary management of stent thrombosis: Predictors of mortality and the role of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2020;96:E8-E16.
    PubMed     Abstract available


    June 2020
  217. NIKOLAKOPOULOS I, Choi JW, Alaswad K, Khatri JJ, et al
    Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2020 Jun 29. doi: 10.1002/ccd.29106.
    PubMed     Abstract available


  218. ROMEO FJ, Seropian IM, Chiabrando JG, Raleigh JV, et al
    Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 28. doi: 10.1002/ccd.29067.
    PubMed     Abstract available


  219. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    PubMed    


  220. BODE MF, Ahmed AA, Baron SJ, Labib SB, et al
    The use of MitraClip to prevent posttranscatheter aortic valve replacement left ventricular "suicide".
    Catheter Cardiovasc Interv. 2020 Jun 26. doi: 10.1002/ccd.29100.
    PubMed     Abstract available


  221. MATSUDA Y, Nai Fovino L, Giacoppo D, Scotti A, et al
    Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29105.
    PubMed     Abstract available


  222. KAPUR NK, Hirst CS, Davila CD, Garcia R, et al
    Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29073.
    PubMed     Abstract available


  223. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2020 Jun 17. doi: 10.1002/ccd.29065.
    PubMed     Abstract available


  224. SATHANANTHAN J, Green P, Finn M, Wood DA, et al
    Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.28981.
    PubMed     Abstract available


  225. MURPHY JL, Patel N, Vengrenyuk Y, Okamoto N, et al
    Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single-center registry study.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.29069.
    PubMed     Abstract available


  226. CHUGH Y, Bavishi C, Mojadidi MK, Elgendy IY, et al
    Safety of transradial access compared to transfemoral access with hemostatic devices (vessel plugs and suture devices) after percutaneous coronary interventions: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.29061.
    PubMed     Abstract available


  227. TANG L, Sorajja P, Mooney M, Garberich R, et al
    Transcatheter aortic valve replacement in patients with severe comorbidities: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jun 8. doi: 10.1002/ccd.29063.
    PubMed     Abstract available


  228. MURPHY AC, Koshy AN, Cameron W, Horrigan M, et al
    Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.28969.
    PubMed     Abstract available


  229. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.28996.
    PubMed     Abstract available


  230. CONROTTO F, D'Ascenzo F, Piroli F, Franze A, et al
    Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29048.
    PubMed     Abstract available


  231. KARACSONYI J, Brilakis ES
    Percutaneous coronary intervention: The "oculosufficient" effect and how to overcome it.
    Catheter Cardiovasc Interv. 2020;95:1267-1268.
    PubMed     Abstract available


  232. TARANTINI G, Nai Fovino L
    Preexisting diastolic dysfunction in patients undergoing TAVR matters-But what about diastole the day after TAVR?
    Catheter Cardiovasc Interv. 2020;95:1338-1339.
    PubMed    


  233. LISKO JC, Block PC
    Pacemaker need after TAVR: Still a conundrum.
    Catheter Cardiovasc Interv. 2020;95:1334-1335.
    PubMed     Abstract available


  234. KRAJCER Z, Postalian A
    Peripheral arterial disease and transcatheter valve replacement outcomes.
    Catheter Cardiovasc Interv. 2020;95:1336-1337.
    PubMed     Abstract available


  235. LANGHAMMER F, Lehner A, Haas NA, Jakob A, et al
    Percutaneous pulmonary valve implantation in a dysfunctional Trifecta(R) bioprothesis after high-pressure balloon fracturing.
    Catheter Cardiovasc Interv. 2020;95:1310-1313.
    PubMed     Abstract available


  236. TANASE D, Georgiev S, Eicken A, Ewert P, et al
    Transcatheter creation of bidirectional cavopulmonary connections by needle punctures in two patients.
    Catheter Cardiovasc Interv. 2020;95:1305-1309.
    PubMed     Abstract available


    May 2020
  237. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2020 May 30. doi: 10.1002/ccd.28998.
    PubMed     Abstract available


  238. SEIF S, Ayuna A, Kumar A, Macdonald J, et al
    Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 May 30. doi: 10.1002/ccd.29050.
    PubMed     Abstract available


  239. SIQUEIRA DA, Simonato M, Ramos AA, Bignoto T, et al
    Mid- to long-term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new-generation, self-expandable system.
    Catheter Cardiovasc Interv. 2020 May 23. doi: 10.1002/ccd.28999.
    PubMed     Abstract available


  240. LI SX, Patel NK, Flannery LD, Cigarroa RJ, et al
    Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28989.
    PubMed     Abstract available


  241. ELEID MF, Zheng PP, Gulati R, Bergman P, et al
    Remote robotic percutaneous coronary intervention: An animal feasibility study.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28978.
    PubMed     Abstract available


  242. TABAZA L, Virk HUH, Janzer S, George JC, et al
    Robotic-assisted percutaneous coronary intervention in a COVID-19 patient.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28982.
    PubMed     Abstract available


  243. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  244. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    PubMed     Abstract available


  245. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    PubMed    


  246. XIONG TY, Liao YB, Li YJ, Chen F, et al
    Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28903.
    PubMed     Abstract available


  247. FERLINI M, Musumeci G, Grieco N, Trabattoni D, et al
    Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28964.
    PubMed     Abstract available


  248. HIGUCHI S, Kabeya Y, Nishina Y, Miura Y, et al
    Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28958.
    PubMed     Abstract available


  249. VIRK HUH, Lakhter V, Tabaza L, George JC, et al
    Do we need robotics for coronary intervention more than ever in the COVID-19 era?
    Catheter Cardiovasc Interv. 2020 May 7. doi: 10.1002/ccd.28949.
    PubMed    


  250. VEULEMANS V, Maier O, Bosbach G, Polzin A, et al
    Novel insights on outcome in horizontal aorta with self-expandable new-generation transcatheter aortic valve replacement devices.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28961.
    PubMed     Abstract available


  251. EL-SABAWI B, Guerrero ME, Eleid MF, Rihal CS, et al
    Acute fulminant hemolysis after transcatheter mitral valve replacement for mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28944.
    PubMed     Abstract available


  252. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    PubMed     Abstract available


  253. LISKO J, Block PC
    The bicuspid aortic valve: Still a toothy problem.
    Catheter Cardiovasc Interv. 2020;95:1193-1194.
    PubMed     Abstract available


  254. TURI ZG
    Closing up after TAVR.
    Catheter Cardiovasc Interv. 2020;95:1176-1177.
    PubMed     Abstract available


  255. SAIA F, Leone A
    Suprasternal access for transcatheter aortic valve implantation: All ways lead to Rome.
    Catheter Cardiovasc Interv. 2020;95:1184-1185.
    PubMed     Abstract available


    April 2020
  256. MISUMIDA N, Anderson JH, Greason KL, Rihal CS, et al
    Antegrade transseptal transcatheter aortic valve replacement: Back to the future?
    Catheter Cardiovasc Interv. 2020 Apr 30. doi: 10.1002/ccd.28934.
    PubMed     Abstract available


  257. XIAO Z, Xu C, Wang D, Zeng H, et al
    The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.
    Catheter Cardiovasc Interv. 2020 Apr 29. doi: 10.1002/ccd.28951.
    PubMed     Abstract available


  258. AZZALINI L, Johal GS, Baber U, Bander J, et al
    Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28931.
    PubMed     Abstract available


  259. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28928.
    PubMed     Abstract available


  260. SADEGHIPOUR P, Talasaz AH, Eslami V, Gerayeli B, et al
    Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28889.
    PubMed     Abstract available


  261. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    PubMed     Abstract available


  262. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    PubMed     Abstract available


  263. HARA H, Kogame N, Takahashi K, Modolo R, et al
    Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28898.
    PubMed     Abstract available


  264. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28904.
    PubMed     Abstract available


  265. THOMSON VS, Varghese MJ, Chacko ST, Varghese L, et al
    Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28897.
    PubMed     Abstract available


  266. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    PubMed     Abstract available


  267. UJIHIRA K, Kohmoto T, Gimelli G, Raval A, et al
    The impact of increased pulmonary arterial pressure on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 3. doi: 10.1002/ccd.28862.
    PubMed     Abstract available


  268. TARANTINI G, Fabris T
    Transcatheter aortic valve replacement without previous conduction disturbances: The importance of preventing iatrogenic pacemaker implantation.
    Catheter Cardiovasc Interv. 2020;95:991-992.
    PubMed     Abstract available


  269. KATARUKA A, Dean LS
    Uncommon but devastating: Stroke after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020;95:893-894.
    PubMed     Abstract available


  270. PERRINO C, Esposito G
    Diastolic dysfunction in severe aortic stenosis: Old but still gold.
    Catheter Cardiovasc Interv. 2020;95:1032-1033.
    PubMed     Abstract available


  271. ARANZULLA TC, Musumeci G
    The first love, you never forget. The last heart valve, you might remember better than the first.
    Catheter Cardiovasc Interv. 2020;95:1022-1023.
    PubMed     Abstract available


  272. BELARDI JA, Lamelas PM
    The new era of ventricular pacing during structural interventions.
    Catheter Cardiovasc Interv. 2020;95:1057-1058.
    PubMed     Abstract available


  273. BUTERA G, Lucchese G, Austin C, Frigiola A, et al
    Hybrid trans-apical atrioventricular valve-in-valve implantation in Fontan circulation.
    Catheter Cardiovasc Interv. 2020;95:950-953.
    PubMed     Abstract available


  274. NAZIF TM, Chen S, Codner P, Grossman PM, et al
    The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions.
    Catheter Cardiovasc Interv. 2020;95:1051-1056.
    PubMed     Abstract available


  275. JONES BM, Jobanputra Y, Krishnaswamy A, Mick S, et al
    Rapid ventricular pacing during transcatheter valve procedures using an internal device and programmer: A demonstration of feasibility.
    Catheter Cardiovasc Interv. 2020;95:1042-1048.
    PubMed     Abstract available


  276. EITAN A, Brinkmann C, Haselbach T, Witt J, et al
    Does valve in valve TAVR carry a higher risk for thromboembolic events compared to native valve TAVR?
    Catheter Cardiovasc Interv. 2020;95:1017-1021.
    PubMed     Abstract available


    March 2020
  277. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    PubMed     Abstract available


  278. KHAN MS, Khan AR, Khan AI, Seo M, et al
    Comparison of revascularization strategies in patients with acute coronary syndrome and multivessel coronary disease: A systematic review and network meta-analysis.
    Catheter Cardiovasc Interv. 2020 Mar 28. doi: 10.1002/ccd.28855.
    PubMed     Abstract available


  279. GIANNINI F, Pagnesi M, Campo G, Donahue M, et al
    Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28798.
    PubMed     Abstract available


  280. CHANDRASEKHAR J, Kerkmeijer LS, Kalkman DN, Sartori S, et al
    Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28853.
    PubMed     Abstract available


  281. SCHUELER R, Ozturk C, Laser JV, Wirth F, et al
    Right ventricular assessment in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28861.
    PubMed     Abstract available


  282. WEBER M, Jaenisch M, Spilker M, Pingel S, et al
    TAVR outcome after reclassification of aortic valve stenosis by using a hybrid continuity equation that combines computed tomography and echocardiography data.
    Catheter Cardiovasc Interv. 2020 Mar 19. doi: 10.1002/ccd.28852.
    PubMed     Abstract available


  283. BRENER SJ, Lembo NJ, Kandzari DE, Sabate M, et al
    Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28858.
    PubMed     Abstract available


  284. MAHOWALD MK, Pislaru SV, Reeder GS, Padang R, et al
    Institutional learning experience for combined edge-to-edge tricuspid and mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28856.
    PubMed     Abstract available


  285. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Response to: Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28828.
    PubMed    


  286. IMAMURA T
    Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28829.
    PubMed    


  287. HENSEY M, Sathananthan J, Alkhodair A, Landes U, et al
    Single-center prospective study examining use of the Wattson temporary pacing guidewire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 9. doi: 10.1002/ccd.28832.
    PubMed     Abstract available


  288. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    PubMed     Abstract available


  289. KERN MJ, Seto AH, Ng AT, Yu JH, et al
    Effects of pericardial tamponade on the hemodynamics of aortic stenosis.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28826.
    PubMed     Abstract available


  290. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    PubMed     Abstract available


  291. PRASAD A, Rosenthal NA, Kartashov A, Knish K, et al
    Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28824.
    PubMed     Abstract available


  292. KHAN MZ, Khan MU, Munir MB, Khan SU, et al
    Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28834.
    PubMed     Abstract available


  293. MURDOCH DJ, Sathananthan J, Hensey M, Alu MC, et al
    Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.
    Catheter Cardiovasc Interv. 2020 Mar 2. doi: 10.1002/ccd.28811.
    PubMed     Abstract available


  294. ROWIN EJ, Kimmelstiel C
    Combined alcohol septal ablation and transcatheter aortic valve replacement: Drunk and playing with fire.
    Catheter Cardiovasc Interv. 2020;95:838-839.
    PubMed     Abstract available


  295. TARANTINI G, Fabris T
    Pure aortic valve regurgitation: SAVR is the gold standard, but TAVR is another gun.
    Catheter Cardiovasc Interv. 2020;95:817-818.
    PubMed     Abstract available


  296. MUSUMECI G, Aranzulla TC
    Choose to fly higher rather than pacing around.
    Catheter Cardiovasc Interv. 2020;95:791-792.
    PubMed     Abstract available


  297. KHAN JM, Lederman RJ
    BATMAN-Savior or vigilante?
    Catheter Cardiovasc Interv. 2020;95:849-850.
    PubMed     Abstract available


  298. ORR WB, Johnson MC, Abarbanell AM, Sintek M, et al
    Recanalization of an atretic intramural left main coronary artery after bypass surgery in a pediatric patient with anomalous aortic origin of the left main coronary artery arising from the right sinus of Valsalva.
    Catheter Cardiovasc Interv. 2020;95:739-742.
    PubMed     Abstract available


  299. RUGE H, Erlebach M, Lieberknecht E, Lange R, et al
    Successful treatment of a paravalvular leak with balloon cracking and valve-in-valve TAVR.
    Catheter Cardiovasc Interv. 2020;95:859-862.
    PubMed     Abstract available


  300. SORENSEN MW, Bauser-Heaton H, Petit CJ
    Percutaneous paraspinal access to the azygos vein to create a neo-vena cava.
    Catheter Cardiovasc Interv. 2020;95:734-738.
    PubMed     Abstract available


  301. GODART F, Baudelet JB, Soquet J, Onorato E, et al
    Antegrade transcatheter closure of a dehiscence of pulmonary bioprosthesis after pulmonary valve replacement with the Occlutech paravalvular leak device.
    Catheter Cardiovasc Interv. 2020;95:855-858.
    PubMed     Abstract available


  302. RAGHUNATHAN D, Hernandez N, Rajagopal K, Jumean M, et al
    Axillary Impella insertion under regional nerve block: A case report.
    Catheter Cardiovasc Interv. 2020;95:E108-E110.
    PubMed     Abstract available


  303. MIRANDA WR, Hagler DJ, Taggart NW, Borlaug BA, et al
    Elevated ventricular filling pressures and long-term survival in adults post-Fontan.
    Catheter Cardiovasc Interv. 2020;95:803-809.
    PubMed     Abstract available


  304. NAKAMURA S, Yamamoto T, Teng Y, Matsumoto S, et al
    Impact of intensively lowered low-density lipoprotein cholesterol on deferred lesion prognosis.
    Catheter Cardiovasc Interv. 2020;95:E100-E107.
    PubMed     Abstract available


    February 2020
  305. KWOK CS, Chatterjee S, Bagur R, Sharma K, et al
    Multiple unplanned readmissions after discharge for an admission with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 28. doi: 10.1002/ccd.28797.
    PubMed     Abstract available


  306. HUDED CP, Kapadia SR, Ballout JA, Krishnaswamy A, et al
    Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28785.
    PubMed     Abstract available


  307. NITA N, Scharnbeck D, Schneider LM, Seeger J, et al
    Predictors of left ventricular reverse remodeling after percutaneous therapy for mitral regurgitation with the MitraClip system.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28779.
    PubMed     Abstract available


  308. POPOVIC B, Molho A, Varlot J, Fay R, et al
    Prognostic influence of acute decompensated heart failure in patients planned for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 26. doi: 10.1002/ccd.28813.
    PubMed     Abstract available


  309. KHEIRI B, Rao SV, Osman M, Simpson TF, et al
    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28800.
    PubMed     Abstract available


  310. NOAMAN S, O'Brien J, Andrianopoulos N, Brennan AL, et al
    Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28802.
    PubMed     Abstract available


  311. AOI S, Baber U, Kovacic JC, Mehran R, et al
    Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28784.
    PubMed     Abstract available


  312. AHMED A, Alsidawi S, Bae R, Cavalcante J, et al
    Changes in quality of life in patients with low-flow aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28805.
    PubMed     Abstract available


  313. REIFF C, Zhingre Sanchez JD, Mattison LM, Iaizzo PA, et al
    3-Dimensional printing to predict paravalvular regurgitation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28783.
    PubMed     Abstract available


  314. OZTURK C, Fasell T, Sinning JM, Werner N, et al
    Left atrial global function in chronic heart failure patients with functional mitral regurgitation after MitraClip.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28775.
    PubMed     Abstract available


  315. RAGHUNATHAN D, Garcia-Sayan E, Dhoble A, Smalling R, et al
    First-in-human report of MitraClip G4 implantation for severe degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28777.
    PubMed     Abstract available


  316. TARANTINI G, Nai Fovino L
    Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;95:363-364.
    PubMed    


  317. AYYOUB A, Levy MS
    Mechanical circulatory support in high-risk percutaneous coronary intervention: IIb or not IIb?
    Catheter Cardiovasc Interv. 2020;95:513-514.
    PubMed    


  318. YILDIZ M, Henry TD
    Preprocedure Thrombolysis In Myocardial Infarction (TIMI) flow grade: Has its time come and gone?
    Catheter Cardiovasc Interv. 2020;95:501-502.
    PubMed    


  319. GOLDSTEIN JA
    Cardiac tamponade in the interventional era: A paradigm shift in etiology and outcomes.
    Catheter Cardiovasc Interv. 2020;95:387-388.
    PubMed    


  320. GAD MM, Elgendy IY, Mahmoud AN, Elbadawi A, et al
    Temporal trends, outcomes, and predictors of mortality after pericardiocentesis in the United States.
    Catheter Cardiovasc Interv. 2020;95:375-386.
    PubMed     Abstract available


  321. SERFAS JD, Turek J, Haney J, Krasuski RA, et al
    Hybrid transcatheter pulmonary valve replacement with a SAPIEN S3 valve after pulmonary artery banding via left lateral thoracotomy.
    Catheter Cardiovasc Interv. 2020;95:E78-E83.
    PubMed     Abstract available


  322. YAP J, Chen S, Stripe BR, Smith TWR, et al
    Transseptal access for left heart structural interventions in the setting of prior atrial septal defect closure.
    Catheter Cardiovasc Interv. 2020;95:414-419.
    PubMed     Abstract available


  323. ALMALLA M, Kersten A, Altiok E, Marx N, et al
    Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:357-362.
    PubMed     Abstract available


  324. SHAH SR, Kiemeneij F, Khuddus MA
    Distal arteriovenous fistula formation after percutaneous coronary intervention: An old complication of a new access site.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28772.
    PubMed     Abstract available


  325. LLOYD JW, Rihal CS, Eleid MF
    Hemodynamics rounds: Hemodynamics of mitral valve interventions.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28755.
    PubMed     Abstract available


  326. ZUSMAN O, Barbash MI, Guetta V, Finkelstein A, et al
    Predicting the risk of late futile outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 5. doi: 10.1002/ccd.28761.
    PubMed     Abstract available


  327. KOPS SA, Pangburn S, Barber BJ, Seckeler MD, et al
    Transcatheter treatment of acquired coronary sinus ostium atresia in a child with complex congenital heart disease.
    Catheter Cardiovasc Interv. 2020;95:E62-E65.
    PubMed     Abstract available


  328. SMITH CL, Hoffman TM, Dori Y, Rome JJ, et al
    Decompression of the thoracic duct: A novel transcatheter approach.
    Catheter Cardiovasc Interv. 2020;95:E56-E61.
    PubMed     Abstract available


  329. IANNACCONE M, Colangelo S, Colombo F, Garbo R, et al
    Rotational atherectomy with the new RotaPro system over RG3 guidewire in subadventitial retrograde highly calcified CTO PCI.
    Catheter Cardiovasc Interv. 2020;95:242-244.
    PubMed     Abstract available


  330. FORD TJ, Khan A, Docherty KF, Jackson A, et al
    Sex differences in procedural and clinical outcomes following rotational atherectomy.
    Catheter Cardiovasc Interv. 2020;95:232-241.
    PubMed     Abstract available


  331. TIAN J, Tang YD, Qiao S, Su X, et al
    Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:587-597.
    PubMed     Abstract available


  332. ZHAO X, Guan C, Yuan J, Xie L, et al
    A modified predilation, sizing, and postdilation scoring system for patients undergoing metallic drug-eluting stent implantations.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:558-564.
    PubMed     Abstract available


    January 2020
  333. MAHMUD E
    The COMPLETE and ISCHEMIA trials: Two contemporary studies showing percutaneous coronary intervention reduces the risk of myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 29. doi: 10.1002/ccd.28723.
    PubMed    


  334. QUADROS A, Belli KC, de Paula JET, de Magalhaes Campos CAH, et al
    Chronic total occlusion percutaneous coronary intervention in Latin America.
    Catheter Cardiovasc Interv. 2020 Jan 28. doi: 10.1002/ccd.28744.
    PubMed     Abstract available


  335. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28742.
    PubMed     Abstract available


  336. BANDYOPADHYAY D, Sartori S, Baber U, Cao D, et al
    The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28752.
    PubMed     Abstract available


  337. BUGANI G, Ponticelli F, Giannini F, Gallo F, et al
    Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 22. doi: 10.1002/ccd.28740.
    PubMed     Abstract available


  338. YOU J, Li H, Guo W, Li J, et al
    Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28712.
    PubMed     Abstract available


  339. ALAWAMI M, Thirunavukarasu S, Ahmed J, El-Omar M, et al
    Intravascular lithotripsy to treat an underexpanded coronary stent: 4-Month angiographic and OCT follow-up.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28738.
    PubMed     Abstract available


  340. BLOCK PC, Kumar A
    Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686.
    PubMed     Abstract available


  341. GILCHRIST IC
    Gastrointestinal bleeding after percutaneous coronary intervention: Not just a short-term complication but a long-term marker of mortality risk.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28680.
    PubMed     Abstract available


  342. TABACHNICK D, Obokhae B, Harrington K, Brown DL, et al
    Assessing the risk of an anomalous circumflex artery using balloon aortic valvuloplasty prior to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28695.
    PubMed     Abstract available


  343. SHATILA W, Krajcer Z
    Transcatheter aortic valve implantation: Do leaks matter?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28684.
    PubMed    


  344. TARANTINI G, Nai Fovino L
    Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28690.
    PubMed     Abstract available


  345. ZHAO ZG, Feng Y, Liao YB, Li YJ, et al
    Reshaping bicuspid aortic valve stenosis with an hourglass-shaped balloon for transcatheter aortic valve replacement: A pilot study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28726.
    PubMed     Abstract available


  346. CAMAJ A, Claessen BE, Mehran R, Yudi MB, et al
    The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
    Catheter Cardiovasc Interv. 2020 Jan 13. doi: 10.1002/ccd.28717.
    PubMed     Abstract available


  347. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  348. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    PubMed     Abstract available


  349. ZHAO X, Li J, Xian Y, Chen J, et al
    Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28719.
    PubMed     Abstract available


  350. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-glutamyl transferase to albumin ratio as a novel predictor of bleeding events and mortality in patients after percutaneous coronary intervention: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28696.
    PubMed     Abstract available


  351. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


  352. SONG L, Sun Z, Guan C, Yan H, et al
    First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes.
    Catheter Cardiovasc Interv. 2020 Jan 7. doi: 10.1002/ccd.28722.
    PubMed     Abstract available


  353. XENOGIANNIS I, Vemmou E, Nikolakopoulos I, Brilakis ES, et al
    Challenges associated with treatment of left internal mammary artery graft thrombosis.
    Catheter Cardiovasc Interv. 2020;95:E17-E20.
    PubMed     Abstract available


  354. MIZUTANI K, Hara M, Nakao K, Yamaguchi T, et al
    Association between debulking area of rotational atherectomy and platform revolution speed-Frequency domain optical coherence tomography analysis.
    Catheter Cardiovasc Interv. 2020;95:E1-E7.
    PubMed     Abstract available


  355. MERINOPOULOS I, Wickramarachchi U, Wardley J, Khanna V, et al
    Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:105-108.
    PubMed     Abstract available


  356. AHLUWALIA M, Jessup M, Forde KA, Sehgal S, et al
    Clinical utility of surveillance and clinically prompted right heart catheterization in patients listed for heart transplantation.
    Catheter Cardiovasc Interv. 2020;95:28-34.
    PubMed     Abstract available


  357. CHAN CY, Chan YH
    Double trapper technique: A novel technique to facilitate retrograde wire externalization in aorto-ostial chronic total occlusion intervention without using snare.
    Catheter Cardiovasc Interv. 2020;95:170-173.
    PubMed     Abstract available


  358. CAPRETTI G, Urena M, Bouleti C, Himbert D, et al
    Transcatheter tricuspid valve-in-valve replacement: Making it simpler.
    Catheter Cardiovasc Interv. 2020;95:65-67.
    PubMed     Abstract available


  359. SHREENIVAS S, Lilly S, Reardon M, Answini GA, et al
    Is two better than one? Re-evaluating the surgical approval process for TAVR.
    Catheter Cardiovasc Interv. 2020;95:68-70.
    PubMed    


    December 2019
  360. KAWAGUCHI T, Yamaji K, Ishizu K, Morinaga T, et al
    Effect of postdilatation following balloon expandable transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Dec 27. doi: 10.1002/ccd.28676.
    PubMed     Abstract available


  361. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    PubMed     Abstract available


  362. GAO G, Zhang D, Song C, Xu H, et al
    Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28673.
    PubMed     Abstract available


  363. LI J, Li Y, Qiu M, Li Z, et al
    Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28653.
    PubMed     Abstract available


  364. NAZIR S, Ahuja KR, Donato A, Grande RD, et al
    Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28648.
    PubMed     Abstract available


  365. YAN L, Li P, Wang Y, Han D, et al
    Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28652.
    PubMed     Abstract available


  366. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    PubMed     Abstract available


  367. KHEIFETS M, Vaknin-Assa H, Greenberg G, Assali A, et al
    Outcomes of primary percutaneous cardiac intervention for ST elevation myocardial infarction with a saphenous vein graft culprit.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28662.
    PubMed     Abstract available


  368. LIMA FV, Kolte D, Rofeberg V, Molino J, et al
    Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: Analysis of the 2014-2015 Nationwide readmissions databases.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28647.
    PubMed     Abstract available


  369. WINKEL MG, Brugger N, Windecker S, Praz F, et al
    An unusual cause of recurrent mitral regurgitation after percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2019 Dec 19. doi: 10.1002/ccd.28651.
    PubMed     Abstract available


  370. NAGARAJA V, Schwarz K, Moss S, Kwok CS, et al
    Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28646.
    PubMed     Abstract available


  371. DUNCAN A, Mirsadree S, Quarto C, Davies S, et al
    Transcatheter aortic valve implantation 10 years after valve-in-valve transcatheter aortic valve implantation for failing aortic valve homograft root replacement.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28658.
    PubMed     Abstract available


  372. BONOW RO, O'Gara PT, Adams DH, Badhwar V, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the Ame
    Catheter Cardiovasc Interv. 2019 Dec 16. doi: 10.1002/ccd.28671.
    PubMed     Abstract available


  373. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  374. RIANGWIWAT T, Mumtaz T, Blankenship JC
    Barriers to use of radial access for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28619.
    PubMed     Abstract available


  375. ALI Z, Sharma P, Mengesha T, Dalmar A, et al
    Early clinical and procedural outcomes in large series of 34-mm self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28634.
    PubMed     Abstract available


  376. XENOGIANNIS I, Choi JW, Alaswad K, Khatri JJ, et al
    Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28614.
    PubMed     Abstract available


  377. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


  378. SCHYMIK G, Wendler O, Hengstenberg C, Ohlmann P, et al
    Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28621.
    PubMed     Abstract available


    November 2019
  379. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    PubMed     Abstract available


  380. OMRAN J, Enezate T, Abdullah O, Al-Dadah A, et al
    Outcomes of fractional flow reserve-guided percutaneous coronary interventions in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28611.
    PubMed     Abstract available


  381. KOTRONIAS RA, Scarsini R, De Maria GL, Rajasundaram S, et al
    Ultrasound guided vascular access site management and left ventricular pacing are associated with improved outcomes in contemporary transcatheter aortic valve replacement: Insights from the OxTAVI registry.
    Catheter Cardiovasc Interv. 2019 Nov 19. doi: 10.1002/ccd.28578.
    PubMed     Abstract available


  382. ASHLEY KE, Hillegass WB
    Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).
    Catheter Cardiovasc Interv. 2019;94:818-819.
    PubMed     Abstract available


  383. HOLLRIEGEL R, Spindler A, Kiefer P, Woitek FJ, et al
    Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28515.
    PubMed     Abstract available


  384. FUGAR S, Behnamfar O, Okoh AK, Alabre AF, et al
    Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28519.
    PubMed     Abstract available


  385. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  386. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    PubMed     Abstract available


  387. SULLIVAN AE, Nanna MG, Rao SV, Cantrell S, et al
    A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28535.
    PubMed     Abstract available


  388. DOWLING C, Firoozi S, Panoulas V, Dalby M, et al
    Initial experience of a self-expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28512.
    PubMed     Abstract available


  389. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    PubMed     Abstract available


  390. XENOGIANNIS I, Nikolakopoulos I, Vemmou E, Brilakis ES, et al
    Chronic total occlusion recanalization for myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28590.
    PubMed     Abstract available


  391. ADAMS HSL, Rajani R, Hildick-Smith D, Redwood S, et al
    "Between a rock and the mitral valve space": Transcatheter mitral valve-in-valve implantation for paravalvular leak and refractory hemolysis complicated by circumflex coronary occlusion.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28573.
    PubMed     Abstract available


  392. PATEL K, Broyd C, Chehab O, Jerrum M, et al
    Transcatheter aortic valve implantation in acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28581.
    PubMed     Abstract available


  393. PAREKH DR, Krajcer Z
    Transapical transcatheter aortic valves. Down but definitely not out for the count.
    Catheter Cardiovasc Interv. 2019;94:745.
    PubMed    


    October 2019
  394. SONG C, Zhou C, Zhang J, Feng X, et al
    Ultrasound controlled paclitaxel releasing system-A novel method for improving the availability of coronary artery drug coated balloon.
    Catheter Cardiovasc Interv. 2019 Oct 29. doi: 10.1002/ccd.28564.
    PubMed     Abstract available


  395. BATCHELOR R, Liu DH, Bloom J, Noaman S, et al
    Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 26. doi: 10.1002/ccd.28561.
    PubMed     Abstract available


  396. ELBADAWI A, Elgendy IY, Mentias A, Saad M, et al
    Outcomes of urgent versus nonurgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Oct 24. doi: 10.1002/ccd.28563.
    PubMed     Abstract available


  397. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    PubMed     Abstract available


  398. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  399. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    PubMed     Abstract available


  400. GOEL S, Pasam RT, Wats K, Patel J, et al
    Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28520.
    PubMed     Abstract available


  401. DE ROSA R, Murray MI, Schranz D, Mas-Peiro S, et al
    Short-term decrease of left atrial size predicts clinical outcome in patients with severe aortic stenosis undergoing TAVR.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28542.
    PubMed     Abstract available


  402. CANTOR WJ, Lavi S, Dzavik V, Cairns J, et al
    Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28540.
    PubMed     Abstract available


  403. YEOH J, Dworakowski R, Hill J, Byrne J, et al
    A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28521.
    PubMed     Abstract available


  404. SINHA S, Khan A, Qureshi AM, Suh W, et al
    Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28505.
    PubMed     Abstract available


  405. COSTA G, Buccheri S, Barbanti M, Picci A, et al
    Outcomes of three different new generation transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28524.
    PubMed     Abstract available


  406. KUNO T, Takagi H, Sugiyama T, Ando T, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28498.
    PubMed     Abstract available


  407. POLETTI E, Azzalini L, Ayoub M, Ojeda S, et al
    Conventional vascular access site approach versus fully trans-wrist approach for chronic total occlusion percutaneous coronary intervention: a multicenter registry.
    Catheter Cardiovasc Interv. 2019 Oct 9. doi: 10.1002/ccd.28513.
    PubMed     Abstract available


    September 2019
  408. DOWLING C, Kondapally Seshasai SR, Firoozi S, Brecker SJ, et al
    Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28504.
    PubMed     Abstract available


  409. HELMY T, Hui DS, Smart S, Lim MJ, et al
    Balloon assisted translocation of the mitral anterior leaflet to prevent left ventricular outflow obstruction (BATMAN): A novel technique for patients undergoing transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2019 Sep 13. doi: 10.1002/ccd.28496.
    PubMed     Abstract available


  410. STAUDACHER DL, Schmitt C, Zirlik A, Zehender M, et al
    Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2019 Sep 11. doi: 10.1002/ccd.28495.
    PubMed     Abstract available


  411. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    PubMed     Abstract available


  412. ATTINGER-TOLLER A, Bhindi R, Perlman GY, Murdoch D, et al
    Mid-term outcome in patients with bicuspid aortic valve stenosis following transcatheter aortic valve replacement with a current generation device: A multicenter study.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28475.
    PubMed     Abstract available


  413. ZHONG C, Rokey R, Rolak S, Mesa J, et al
    Pregnancy and transcatheter aortic valve replacement in a severely stenotic Freestyle full aortic root stentless bioprosthesis.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28481.
    PubMed     Abstract available


  414. HIRAI T, Kearney K, Kataruka A, Gosch KL, et al
    Initial report of safety and procedure duration of robotic-assisted chronic total occlusion coronary intervention.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28477.
    PubMed     Abstract available


  415. JOGU HR, Arora S, Strassle PD, Patel C, et al
    Impact of age and comorbidities on the effect of transcatheter versus surgical mitral valve repair on inpatient outcomes.
    Catheter Cardiovasc Interv. 2019 Sep 2. doi: 10.1002/ccd.28479.
    PubMed     Abstract available


  416. TARANTINI G, Giacoppo D
    Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery?
    Catheter Cardiovasc Interv. 2019;94:385-386.
    PubMed     Abstract available


  417. KORNOWSKI R
    Transcatheter aortic valve replacement for oncology patients with severe symptomatic aortic stenosis: New hope for a complicated medical condition.
    Catheter Cardiovasc Interv. 2019;94:446-447.
    PubMed     Abstract available


  418. CILINGIROGLU M, Margmakiolis K
    Predilatation for transcatheter aortic valve replacement: Still have a role?
    Catheter Cardiovasc Interv. 2019;94:479-480.
    PubMed     Abstract available


  419. ZAHR F, Cigarroa JE
    Replacing the mitral valve alone does not completely fix the heart!
    Catheter Cardiovasc Interv. 2019;94:467-468.
    PubMed     Abstract available


  420. MUSUMECI G, Cinconze S
    Relationship volume-outcome for transcatheter mitral-valve repair: When technique matters.
    Catheter Cardiovasc Interv. 2019;94:436-437.
    PubMed     Abstract available


    August 2019
  421. YOKOYAMA H, Mizuno S, Saito S
    Subacute hemolytic anemia after transcatheter edge-to-edge mitral valve repair: A case report.
    Catheter Cardiovasc Interv. 2019 Aug 30. doi: 10.1002/ccd.28482.
    PubMed     Abstract available


  422. RIZIK DG, Burke RF, Goldstein JA
    Urgent mechanical circulatory support and transcatheter mitral valve repair for refractory hemodynamic compromise.
    Catheter Cardiovasc Interv. 2019 Aug 27. doi: 10.1002/ccd.28439.
    PubMed     Abstract available


  423. PAGNOTTA PA, Sanz-Sanchez J, Regazzoli D, Ferrante G, et al
    One-stop-shop totally percutaneous approach for severe aortic and mitral regurgitation in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Aug 27. doi: 10.1002/ccd.28466.
    PubMed     Abstract available


  424. EUDAILEY KW, Olds A, Lewis CT, Nazif TN, et al
    Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach.
    Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28460.
    PubMed     Abstract available


  425. KANDZARI DE, Karmpaliotis D, Kini AS, Moses JW, et al
    Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPER
    Catheter Cardiovasc Interv. 2019 Aug 24. doi: 10.1002/ccd.28436.
    PubMed     Abstract available


  426. GOEL S, Pasam RT, Raheja H, Gotesman J, et al
    Left main percutaneous coronary intervention-Radial versus femoral access: A systematic analysis.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28451.
    PubMed     Abstract available


  427. KANDA BS, Hoyt NE, Tavaf-Motamen H
    Paravalvular leak closure of acute mitral valve ring dehiscence during mitral valve-in-ring procedure.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28443.
    PubMed     Abstract available


  428. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28440.
    PubMed     Abstract available


  429. TARANTINI G, Nai Fovino L, D'Errigo P, Rosato S, et al
    Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28447.
    PubMed     Abstract available


  430. ANANTHA-NARAYANAN M, Malik U, Mbai M, Megaly M, et al
    Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 16. doi: 10.1002/ccd.28444.
    PubMed     Abstract available


  431. POTTS J, Mohamed MO, Lopez Mattei JC, Iliescu CA, et al
    Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28432.
    PubMed     Abstract available


  432. KOGAME N, Chichareon P, De Wilder K, Takahashi K, et al
    Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28428.
    PubMed     Abstract available


  433. ROULE V, Schwob L, Lemaitre A, Bignon M, et al
    Residual atherothrombotic burden after primary percutaneous coronary intervention and myocardial reperfusion-An optical frequency domain imaging study.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28429.
    PubMed     Abstract available


  434. DOSHI R, Patel K, Desai R, Patel P, et al
    Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28431.
    PubMed     Abstract available


  435. IANNACCONE M, Abdirashid M, Annone U, Saint-Hilary G, et al
    Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention: A network meta-analysis of randomized and propensity matching studies.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28410.
    PubMed     Abstract available


  436. KAMPAKTSIS PN, Vavuranakis M, Choi DY, Sherifi I, et al
    Prognostic role of diastolic dysfunction in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28426.
    PubMed     Abstract available


  437. WATANABE H, Shiomi H, Morimoto T, Furukawa Y, et al
    Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420.
    PubMed     Abstract available


  438. AL-ANI A, Hoffmann P, von Lueder T, Opdahl A, et al
    Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Aug 4. doi: 10.1002/ccd.28419.
    PubMed     Abstract available


    July 2019
  439. FLAHERTY MP, Moses JW, Westenfeld R, Palacios I, et al
    Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Catheter Cardiovasc Interv. 2019 Jul 29. doi: 10.1002/ccd.28400.
    PubMed     Abstract available


  440. CASTRO-MEJIA AF, Ortega-Armas ME, Mejia-Renteria H, Gonzalo N, et al
    Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jul 26. doi: 10.1002/ccd.28404.
    PubMed     Abstract available


  441. KAR S
    Systematic review of alternative access for cardiac catheterization and percutaneous coronary intervention: Dorsal distal radial and ulnar artery catheterization.
    Catheter Cardiovasc Interv. 2019 Jul 22. doi: 10.1002/ccd.28398.
    PubMed     Abstract available


  442. GASPARINI GL, Garbo R, Gagnor A, Oreglia J, et al
    Feasibility and safety of distal radial access for percutaneous coronary intervention using a 7 FR sheath.
    Catheter Cardiovasc Interv. 2019 Jul 21. doi: 10.1002/ccd.28397.
    PubMed    


  443. SAADAT N, Saadatagah S, Aghajani Nargesi A, Alidoosti M, et al
    Short-term safety and long-term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28396.
    PubMed     Abstract available


  444. LI Y, Tian F, Wang J, Xie M, et al
    Pseudoaneurysm of the non-coronary sinus of Valsalva: A rare complication of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28407.
    PubMed     Abstract available


  445. PINO JE, Shah V, Ramos Tuarez FJ, Kreidieh OI, et al
    The utility of pulmonary function testing in the preoperative risk stratification of patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28402.
    PubMed     Abstract available


  446. RAFEEDHEEN R, Agarwal SK, Meek JC, Uretsky BF, et al
    Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28399.
    PubMed     Abstract available


  447. KIRTANE AJ, Yeung AC, Ball M, Carr J, et al
    Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.
    Catheter Cardiovasc Interv. 2019 Jul 13. doi: 10.1002/ccd.28392.
    PubMed     Abstract available


  448. MOMENAH TS, Alsahari A, Ahmed E, Al Khalaf K, et al
    Transcatheter mitral valve-in-valve implantation in a pediatric patient.
    Catheter Cardiovasc Interv. 2019 Jul 11. doi: 10.1002/ccd.28390.
    PubMed     Abstract available


  449. MADUKAUWA-DAVID ID, Sadri V, Kamioka N, Midha PA, et al
    Transcatheter aortic valve deployment influences neo-sinus thrombosis risk: An in vitro flow study.
    Catheter Cardiovasc Interv. 2019 Jul 9. doi: 10.1002/ccd.28388.
    PubMed     Abstract available


    June 2019
  450. HE Y, Cheng XF, Wang K, Liu T, et al
    Predictive value of combining the SYNTAX score with reactive hyperemia index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 29. doi: 10.1002/ccd.28384.
    PubMed     Abstract available


  451. AL-KHADRA Y, Alraies MC, Darmoch F, Pacha HM, et al
    Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jun 28. doi: 10.1002/ccd.28383.
    PubMed     Abstract available


  452. HIRAI T, Jacob D, Main ML, Grantham JA, et al
    A case of robotic assisted percutaneous coronary intervention of the left main coronary artery in a patient with very late baffle stenosis after surgical correction of anomalous left coronary artery from the pulmonary artery.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28382.
    PubMed     Abstract available


  453. SHAH R, Naz A
    Postprocedure bivalirudin infusion for primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 26. doi: 10.1002/ccd.28377.
    PubMed    


  454. NANJUDAPPA A, Bhagat A, Bates MC
    A rare cause of stroke after transcatheter aortic valve replacement: Retained foreign body.
    Catheter Cardiovasc Interv. 2019 Jun 24. doi: 10.1002/ccd.28374.
    PubMed     Abstract available


  455. WERNER N, Puls M, Baldus S, Lubos E, et al
    Gender-related differences in patients undergoing transcatheter mitral valve interventions in clinical practice: 1-year results from the German TRAMI registry.
    Catheter Cardiovasc Interv. 2019 Jun 24. doi: 10.1002/ccd.28372.
    PubMed     Abstract available


  456. CHANDIRAMANI R, Chen H, Aoi S, Giustino G, et al
    Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369.
    PubMed     Abstract available


  457. CHEN W, Lu D, Huang Z, Xiao L, et al
    Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2019 Jun 10. doi: 10.1002/ccd.28368.
    PubMed    


  458. KEYMEL S, Papadopoulos G, Minol JP, Blehm A, et al
    Patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transapical transcatheter aortic valve replacement-Is there a need for increased attention?
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28358.
    PubMed     Abstract available


  459. TRIPATHI B, Yeh RW, Bavishi CP, Sardar P, et al
    Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28344.
    PubMed     Abstract available


  460. STACHON P, Kaier K, Heidt T, Bothe W, et al
    Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28361.
    PubMed     Abstract available


  461. PRICE DJ, Levy MS
    CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone?
    Catheter Cardiovasc Interv. 2019;93:1253-1254.
    PubMed     Abstract available


  462. BLOCK PC, Lisko JC
    Thrombocytopenia after transcatheter aortic valve replacement: What is really going on?
    Catheter Cardiovasc Interv. 2019;93:1352-1353.
    PubMed     Abstract available


    May 2019
  463. MONTERO CABEZAS JM, Abou R, Goedemans L, Aguero J, et al
    Procedural-related coronary atrial branch occlusion during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and atrial arrhythmias at follow-up.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28351.
    PubMed     Abstract available


  464. AMAT-SANTOS IJ, Gutierrez H, Sathananthan J, Webb JG, et al
    Fracture of small Mitroflow(R) aortic bioprosthesis following valve-in-valve transcatheter aortic valve replacement with ACURATE neo valve-From bench testing to clinical practice.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28347.
    PubMed     Abstract available


  465. KIM N, Lee JH, Jang SY, Bae MH, et al
    Intravascular modality-guided versus angiography-guided percutaneous coronary intervention in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 27. doi: 10.1002/ccd.28359.
    PubMed     Abstract available


  466. CHEN Y, Yin T, Xi S, Zhang S, et al
    A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28325.
    PubMed     Abstract available


  467. KOYAMA Y, Yamamoto M, Kagase A, Tsujimoto S, et al
    Prognostic impact and periprocedural complications of chronic steroid therapy in patients following transcatheter aortic valve replacement: Propensity-matched analysis from the Japanese OCEAN registry.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28332.
    PubMed     Abstract available


  468. BARBARAWI M, Kheiri B, Zayed Y, Barbarawi O, et al
    Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28280.
    PubMed     Abstract available


  469. CONZELMANN LO, Wurth A, Balthasar V, Neuber C, et al
    Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28339.
    PubMed     Abstract available


  470. UESHIMA D, Barioli A, Nai Fovino L, D'Amico G, et al
    The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 May 17. doi: 10.1002/ccd.28335.
    PubMed     Abstract available


  471. DESCH S, Thiele H
    Letter commenting on: Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis (Kundu et al. Catheter Cardio
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28331.
    PubMed    


  472. KUNDU A, Sardar P, Kakouros N, Fisher DZ, et al
    Rebuttal: Response to letter by Desch et al. regarding "Outcomes of multivessel vs. culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-ana
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28334.
    PubMed    


  473. OJEDA S, Hidalgo F, Romero M, Mazuelos F, et al
    Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2019 May 7. doi: 10.1002/ccd.28327.
    PubMed     Abstract available


  474. IBRAHIM H, Vapheas E, Shah B, AlKhalil A, et al
    Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28320.
    PubMed     Abstract available


  475. SEKIGUCHI M, Muramatsu T, Kishi K, Muto M, et al
    Assessment of reattempted percutaneous coronary intervention strategy for chronic total occlusion after prior failed procedures: Analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28315.
    PubMed     Abstract available


  476. KARATASAKIS A, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention failure: Learning from failure.
    Catheter Cardiovasc Interv. 2019;93:1039-1040.
    PubMed     Abstract available


  477. KALYANASUNDARAM A, Seth A
    Chronic total occlusion or non-chronic total occlusion percutaneous coronary intervention: Do myocytes really care?
    Catheter Cardiovasc Interv. 2019;93:1067-1068.
    PubMed     Abstract available


  478. ASHLEY KE, Hillegass WB
    Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present.
    Catheter Cardiovasc Interv. 2019;93:1137.
    PubMed     Abstract available


    April 2019
  479. ATTINGER-TOLLER A, Htun NM, Murdoch D, Perlman GY, et al
    Transcatheter aortic valve-in-valve implantation for failed surgical bioprosthetic valves. A minimalist approach without contrast aortography or echocardiographic guidance.
    Catheter Cardiovasc Interv. 2019 Apr 30. doi: 10.1002/ccd.28299.
    PubMed     Abstract available


  480. JUNQUERA L, Freitas-Ferraz AB, Padron R, Silva I, et al
    Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28323.
    PubMed     Abstract available


  481. SEPPELT PC, Zappel J, Weiler H, Mas-Peiro S, et al
    Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28319.
    PubMed     Abstract available


  482. MOHANANEY D, Villablanca P, Gupta T, Ranka S, et al
    Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28310.
    PubMed     Abstract available


  483. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, Mendez-Bailon M, et al
    Impact of COPD on outcomes in hospitalized patients treated with transcatheter aortic valve implantation or surgical aortic valve replacement in Spain.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28321.
    PubMed     Abstract available


  484. VAN NUNEN LX, van 't Veer M, Zimmermann FM, Wijnbergen I, et al
    Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28289.
    PubMed     Abstract available


  485. ZHOU D, Pan W, Wang J, Wu Y, et al
    VitaFlow transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28226.
    PubMed     Abstract available


  486. HANNAN EL, Wu Y, Tamis-Holland J, Jacobs AK, et al
    Sex differences in the treatment and outcomes of patients hospitalized with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Apr 22. doi: 10.1002/ccd.28286.
    PubMed     Abstract available


  487. NISHIMURA RA, O'Gara PT, Bavaria JE, Brindis RG, et al
    2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document: A proposal to optimize care for patients with valvular heart disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American Socie
    Catheter Cardiovasc Interv. 2019 Apr 19. doi: 10.1002/ccd.28196.
    PubMed    


  488. BERI N, Singh GD, Smith TW, Fan D, et al
    Iatrogenic atrial septal defect closure after transseptal mitral valve interventions: Indications and outcomes.
    Catheter Cardiovasc Interv. 2019 Apr 19. doi: 10.1002/ccd.28294.
    PubMed     Abstract available


  489. YOSHIJIMA N, Yanagisawa R, Hase H, Tanaka M, et al
    Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2019 Apr 11. doi: 10.1002/ccd.28279.
    PubMed     Abstract available


  490. RAJ L, Mehra A, Shavelle DM
    Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure.
    Catheter Cardiovasc Interv. 2019 Apr 10. doi: 10.1002/ccd.28221.
    PubMed     Abstract available


  491. KWOK CS, Sirker A, Farmer AD, Kontopantelis E, et al
    In-hospital gastrointestinal bleeding following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Apr 8. doi: 10.1002/ccd.28222.
    PubMed     Abstract available


  492. LANE CE, Eleid MF, Holmes DR Jr
    An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.
    Catheter Cardiovasc Interv. 2019 Apr 5. doi: 10.1002/ccd.28220.
    PubMed     Abstract available


  493. MARMAGKIOLIS K, Hakeem A, Ebersole DG, Iliescu C, et al
    Clinical outcomes of percutaneous mitral valve repair with MitraClip for the management of functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2019 Apr 1. doi: 10.1002/ccd.28203.
    PubMed     Abstract available


    March 2019
  494. AKTUERK D, Jansz P, Shaw M, Muller DWM, et al
    Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28210.
    PubMed     Abstract available


  495. SAIA F, Palmerini T, Compagnone M, Battistini P, et al
    Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28211.
    PubMed     Abstract available


  496. ABAWI M, van Gils L, Agostoni P, van Mieghem NM, et al
    Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175.
    PubMed     Abstract available


  497. BUTTER C, Okamoto M, Schymik G, Jacobshagen C, et al
    Degree of valve calcification in patients undergoing transfemoral transcatheter aortic valve implantation with and without balloon aortic valvuloplasty: Findings from the multicenter EASE-IT TF registry.
    Catheter Cardiovasc Interv. 2019 Mar 13. doi: 10.1002/ccd.28164.
    PubMed     Abstract available


  498. LAM DH, Itani M, Dvir D
    Evaluation of failed prosthetic valves in the valve-in-valve era: Potential for utilizing positron emission tomography/computed tomography to recognize infective endocarditis.
    Catheter Cardiovasc Interv. 2019 Mar 11. doi: 10.1002/ccd.28185.
    PubMed     Abstract available


  499. BELARDI JA, Lamelas PM
    Transcatheter aortic valve replacement hemodynamic durability: Still in question?
    Catheter Cardiovasc Interv. 2019;93:739.
    PubMed     Abstract available


  500. KUMAR V, Seth A
    Transcatheter aortic valve replacement: Protect the kidneys to protect the patient.
    Catheter Cardiovasc Interv. 2019;93:749-750.
    PubMed     Abstract available


  501. SHATILA W, Krajcer Z
    Does single-valve surgery cause ischemia?
    Catheter Cardiovasc Interv. 2019;93:590-591.
    PubMed     Abstract available


  502. VETROVEC GW
    Expanding opportunities for stent optimization.
    Catheter Cardiovasc Interv. 2019;93:611-612.
    PubMed     Abstract available


  503. CLAESSEN BE, Mehran R
    Hope for the best, prepare for the worst: How to manage coronary perforations.
    Catheter Cardiovasc Interv. 2019;93:E255-E256.
    PubMed     Abstract available


  504. GILCHRIST IC
    Treating hemolysis due to perivalvular leaks: It is all about modifying micro-jets and not the volume of regurgitation.
    Catheter Cardiovasc Interv. 2019;93:720-721.
    PubMed     Abstract available


    February 2019
  505. UESHIMA D, Masiero G, Schiavo A, Badawy MRA, et al
    Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile.
    Catheter Cardiovasc Interv. 2019 Feb 28. doi: 10.1002/ccd.28124.
    PubMed     Abstract available


  506. ATTI V, Patel NJ, Kumar V, Tripathi B, et al
    Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161.
    PubMed     Abstract available


  507. AL-OGAILI A, Fugar S, Okoh A, Kolkailah AA, et al
    Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28156.
    PubMed     Abstract available


  508. RAMZY J, Andrianopoulos N, Roberts L, Duffy SJ, et al
    Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28145.
    PubMed     Abstract available


  509. JAMES TM, Stamou SC, Rothenberg M, Nores MA, et al
    Transcatheter aortic valve in valve implantation with bioprosthetic valve fracture.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28113.
    PubMed     Abstract available


  510. KIM J, Alakbarli J, Palumbo MC, Xie LX, et al
    Left ventricular geometry predicts optimal response to percutaneous mitral repair via MitraClip: Integrated assessment by two- and three-dimensional echocardiography.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28147.
    PubMed     Abstract available


  511. LLOYD JW, Joseph TA, Cabalka AK, Guerrero M, et al
    Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28149.
    PubMed     Abstract available


  512. D'ANCONA G, Ince H, Schillinger W, Senges J, et al
    Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry).
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28127.
    PubMed     Abstract available


  513. BLACKMAN DJ, Van Gils L, Bleiziffer S, Gerckens U, et al
    Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28120.
    PubMed     Abstract available


  514. TAKAYUKI G, Volker H, Axel H, Dirk F, et al
    Transfemoral transcatheter aortic valve implantation after aortic valve repair with HAART 300 device.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28129.
    PubMed     Abstract available


  515. CHEN B, Dean LS
    HAS-BLED for predicting transfemoral transcatheter aortic valve replacement outcomes: Enough to tamponade the problem?
    Catheter Cardiovasc Interv. 2019;93:E202-E203.
    PubMed     Abstract available


  516. KHAN A, Dangas G
    Positioning of self-expanding transcatheter valve prostheses.
    Catheter Cardiovasc Interv. 2019;93:530-531.
    PubMed     Abstract available


  517. PAREKH DR, Krajcer Z
    Percutaneous pulmonary valve implantation: It's not like the aortic valve.
    Catheter Cardiovasc Interv. 2019;93:464-465.
    PubMed     Abstract available


  518. BELARDI JA, Lamelas P
    Impella support for chronic total occlusions angioplasty: A good start.
    Catheter Cardiovasc Interv. 2019;93:E191-E192.
    PubMed     Abstract available


  519. DAVIDSON LJ, Davidson CJ
    CAD strategy in the TAVR era.
    Catheter Cardiovasc Interv. 2019;93:553-554.
    PubMed     Abstract available


  520. SETO AH, Kern MJ
    Every TAVR deserves a cardiac implantable electronic device specialist.
    Catheter Cardiovasc Interv. 2019;93:E200-E201.
    PubMed     Abstract available


  521. WOODY WW
    Radial first, radial second, and beyond.
    Catheter Cardiovasc Interv. 2019;93:562.
    PubMed    


  522. KIRTANE AJ
    Re-wire but don't necessarily kiss twice for bifurcations treated with two stents: The DR-crush technique.
    Catheter Cardiovasc Interv. 2019;93.
    PubMed    


  523. AL-HIJJI MA, El Sabbagh A, Guerrero ME, Rihal CS, et al
    Paravalvular leak repair after balloon-expandable transcatheter mitral valve implantation in mitral annular calcification: Early experience and lessons learned.
    Catheter Cardiovasc Interv. 2019 Feb 9. doi: 10.1002/ccd.28131.
    PubMed     Abstract available


  524. WANG Y, Zhao HW, Wang CF, Fan CY, et al
    Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28087.
    PubMed     Abstract available


  525. HARFOUCH B, Prasad A
    The use of ultra low contrast volume during percutaneous coronary intervention and risk of acute kidney injury: How low can we go?
    Catheter Cardiovasc Interv. 2019;93:231-232.
    PubMed     Abstract available


  526. HALL AB, Brilakis ES
    Hybrid 2.0: Subintimal plaque modification for facilitation of future success in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019;93:199-201.
    PubMed     Abstract available


  527. BELARDI J, Lamelas P
    TAVR for aortic valve regurgitation: Ready for a randomized trial?
    Catheter Cardiovasc Interv. 2019;93:354-355.
    PubMed     Abstract available


  528. GOLESKI PJ, Nakamura K, Liebeskind E, Salisbury AC, et al
    Revascularization of coronary chronic total occlusions with subintimal tracking and reentry followed by deferred stenting: Experience from a high-volume referral center.
    Catheter Cardiovasc Interv. 2019;93:191-198.
    PubMed     Abstract available


  529. MORGAN GJ, Sadeghi S, Salem MM, Wilson N, et al
    SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:324-329.
    PubMed     Abstract available


  530. ROSENBERG M, Waliszewski M, Chin K, Ahmad WAW, et al
    Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry.
    Catheter Cardiovasc Interv. 2019;93:181-188.
    PubMed     Abstract available


  531. CLAESSEN BE, Henriques JPS, Vendrik J, Boerlage-van Dijk K, et al
    Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial.
    Catheter Cardiovasc Interv. 2019;93:216-221.
    PubMed     Abstract available


  532. BLACHUTZIK F, Achenbach S, Trobs M, Marwan M, et al
    Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.
    Catheter Cardiovasc Interv. 2019;93:202-207.
    PubMed     Abstract available


  533. INGRASSIA J, Youn YJ, Lee J, Azrin M, et al
    Novel approach to coronary artery perforation repair.
    Catheter Cardiovasc Interv. 2019;93:E98-E100.
    PubMed     Abstract available


    January 2019
  534. RUBIMBURA V, Rostain L, Duval AM, Akakpo S, et al
    Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study.
    Catheter Cardiovasc Interv. 2019 Jan 31. doi: 10.1002/ccd.28084.
    PubMed     Abstract available


  535. WU K, Huang Z, Zhong Z, Liao H, et al
    Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28093.
    PubMed     Abstract available


  536. REED GW, Rossi JE, Masri A, Griffin BP, et al
    Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28107.
    PubMed     Abstract available


  537. AL-HIJJI MA, Zack CJ, Nkomo VT, Pislaru SV, et al
    Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jan 27. doi: 10.1002/ccd.28074.
    PubMed     Abstract available


  538. SHARMA SK, Bolduan RW, Patel MR, Martinsen BJ, et al
    Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28099.
    PubMed     Abstract available


  539. RATTANAWONG P, Kanitsoraphan C, Kewcharoen J, Riangwiwat T, et al
    Chronic kidney disease is associated with increased mortality and procedural complications in transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28102.
    PubMed     Abstract available


  540. FLINT K, Brieke A, Wiktor D, Carroll J, et al
    Percutaneous edge-to-edge mitral valve repair may rescue select patients in cardiogenic shock: Findings from a single center case series.
    Catheter Cardiovasc Interv. 2019 Jan 24. doi: 10.1002/ccd.28089.
    PubMed     Abstract available


  541. FAGGIONI M, Baber U, Chandrasekhar J, Sartori S, et al
    Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2019 Jan 17. doi: 10.1002/ccd.28033.
    PubMed     Abstract available


  542. JIA S, Zhao Y, Yang J, Zhao X, et al
    Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
    PubMed     Abstract available


  543. KHEIRI B, Abdalla A, Osman M, Barbarawi M, et al
    Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28075.
    PubMed     Abstract available


  544. POTTS J, Nagaraja V, Al Suwaidi J, Brugaletta S, et al
    The influence of Elixhauser comorbidity index on percutaneous coronary intervention outcomes.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28072.
    PubMed     Abstract available


  545. WANG H, Ning X, Zhu C, Yin D, et al
    Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28057.
    PubMed     Abstract available


  546. OKOH AK, Haik N, Singh S, Kaur K, et al
    Discharge disposition of older patients undergoing trans-catheter aortic valve replacement and its impact on survival.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28069.
    PubMed     Abstract available


  547. CHAN CY, Wu EB, Yan BP, Tsuchikane E, et al
    Procedure failure of chronic total occlusion percutaneous coronary intervention in an algorithm driven contemporary Asia-Pacific Chronic Total Occlusion Club (APCTO Club) multicenter registry.
    Catheter Cardiovasc Interv. 2019 Jan 3. doi: 10.1002/ccd.28064.
    PubMed     Abstract available


  548. AHN SG, Lee JW, Youn YJ, Lee SH, et al
    In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2019 Jan 2. doi: 10.1002/ccd.28032.
    PubMed     Abstract available


  549. GIRI JS, Szerlip M, Devireddy C, Cox DA, et al
    SCAI 2018 Think Tank Proceedings: "What should the role of the surgeon be in TAVR, both as a co-operator and in-patient evaluation for TAVR?
    Catheter Cardiovasc Interv. 2019;93:178-179.
    PubMed    


  550. ALDERWEIRELDT AS, De Wolf D
    Percutaneous closure of paravalvular leak after Cone repair for Ebstein's anomaly.
    Catheter Cardiovasc Interv. 2019;93:E46-E48.
    PubMed     Abstract available


  551. SATHANANDAM S, Balduf K, Chilakala S, Washington K, et al
    Role of Transcatheter patent ductus arteriosus closure in extremely low birth weight infants.
    Catheter Cardiovasc Interv. 2019;93:89-96.
    PubMed     Abstract available


  552. GARCIA-GUIMARAES M, Antuna P, Cuesta J, Alfonso F, et al
    Early restenosis of resorbable magnesium scaffolds: Optical coherence tomography findings.
    Catheter Cardiovasc Interv. 2019;93:79-81.
    PubMed     Abstract available


  553. FIOCCA L, Cereda AF, Bernelli C, Canova PA, et al
    Autologous blood reinfusion during iatrogenic acute hemorrhagic cardiac tamponade: Safety and feasibility in a cohort of 30 patients.
    Catheter Cardiovasc Interv. 2019;93:E56-E62.
    PubMed     Abstract available


  554. BAQUET M, Grundmann D, Schmidt W, Thienel M, et al
    Hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in KUM ABSORB registry.
    Catheter Cardiovasc Interv. 2019;93:71-78.
    PubMed     Abstract available


    December 2018
  555. CANNON LA, Kimmelstiel CD, White A, Hill R, et al
    Clinical outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
    Catheter Cardiovasc Interv. 2018 Dec 30. doi: 10.1002/ccd.28044.
    PubMed     Abstract available


  556. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
    Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
    PubMed     Abstract available


  557. CHOI CH, Cheng V, Malaver D, Kon N, et al
    A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28039.
    PubMed     Abstract available


  558. CHEN L, Mantri N, Eng ML, Wung W, et al
    Intraprocedural direct left atrial and wedge pressure correlation during transcatheter mitral valve repair: Results from a single center registry.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28035.
    PubMed     Abstract available


  559. LIU S, Song C, Zhao Y, Guan C, et al
    Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28030.
    PubMed     Abstract available


  560. NEUPANE S, Khawaja O, Edla S, Singh H, et al
    Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28045.
    PubMed     Abstract available


  561. FABRIS E, Ottervanger JP, Hermanides RS, Ten Berg JM, et al
    Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043.
    PubMed     Abstract available


  562. ELGENDY IY, Mahmoud AN, Elbadwai A, Elgendy AY, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians.
    Catheter Cardiovasc Interv. 2018 Dec 19. doi: 10.1002/ccd.28050.
    PubMed     Abstract available


  563. POTTER BJ, Thompson C, Green P, Clancy S, et al
    Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28014.
    PubMed     Abstract available


  564. GAO G, Zhao Y, Zhang D, He Y, et al
    Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28053.
    PubMed     Abstract available


  565. SCHECHTER M, Balanescu DV, Donisan T, Dayah TJ, et al
    An update on the management and outcomes of cancer patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28052.
    PubMed     Abstract available


  566. IANNACCONE M, D'ascenzo F, Piazza F, De Benedictis M, et al
    Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28037.
    PubMed     Abstract available


  567. FINKELSTEIN A, Rozenbaum Z, Zhitomirsky S, Halkin A, et al
    Safety outcomes of new versus old generation transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28021.
    PubMed     Abstract available


  568. CORCOS T
    Distal radial access for coronary angiography and percutaneous coronary intervention: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Dec 11. doi: 10.1002/ccd.28016.
    PubMed     Abstract available


  569. ANDO T, Aoi S, Ashraf S, Villablanca PA, et al
    Transradial versus transfemoral percutaneous coronary intervention of left main disease: A systematic review and meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28025.
    PubMed     Abstract available


  570. FERNANDEZ-LOPEZ L, Chevalier B, Lefevre T, Spaziano M, et al
    Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28024.
    PubMed     Abstract available


  571. GUEDENEY P, Tchetche D, Petronio AS, Mehilli J, et al
    Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012.
    PubMed     Abstract available


  572. AHMED A, Akintoye E, Adegbala O, Yassin A, et al
    In-hospital outcomes of transcatheter mitral valve repair with Mitraclip in patients with pulmonary hypertension: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2018 Dec 2. doi: 10.1002/ccd.27997.
    PubMed     Abstract available


    November 2018
  573. YOUNIS A, Orvin K, Nof E, Barabash IM, et al
    The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.28017.
    PubMed     Abstract available


  574. FINN MT, Doshi D, Cleman J, Song L, et al
    Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.27958.
    PubMed     Abstract available


  575. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
    PubMed     Abstract available


  576. TAKAGI H, Hari Y, Kawai N, Ando T, et al
    Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27948.
    PubMed     Abstract available


  577. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27986.
    PubMed     Abstract available


  578. ABDELGHANI M, Allali A, Kaur J, Hemetsberger R, et al
    Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27977.
    PubMed     Abstract available


  579. JACOBZON E, Wolak A, Fink D, Silberman S, et al
    Delayed aortic dissection and valve thrombosis after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27994.
    PubMed     Abstract available


  580. LEHNER A, Herrmann FE, Mehilli J, Haas NA, et al
    Edwards Sapien 3 transcatheter aortic valve implantation for management of severe aortic regurgitation in a teenage patient with corrected atrioventricular septal defect and progressive left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27975.
    PubMed     Abstract available


  581. BROUWER J, Gheorghe L, Nijenhuis VJ, Ten Berg JM, et al
    Insight on patient specific computer modeling of transcatheter aortic valve implantation in patients with bicuspid aortic valve disease.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27990.
    PubMed     Abstract available


  582. JOSEPH TA, Eleid MF, Cabalka AK, Maalouf JF, et al
    Long-term outcomes of melody valve-in-valve implantation for bioprosthetic mitral valve dysfunction.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27988.
    PubMed     Abstract available


  583. WALTERS D, Reeves RR, Patel M, Naghi J, et al
    Complex robotic compared to manual coronary interventions: 6- and 12-month outcomes.
    Catheter Cardiovasc Interv. 2018 Nov 19. doi: 10.1002/ccd.27867.
    PubMed     Abstract available


  584. SCHUMACHER SP, Driessen RS, Stuijfzand WJ, Raijmakers PG, et al
    Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non-occlusive lesions.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27945.
    PubMed     Abstract available


  585. CHENG R, Kar S, Siegel RJ, Nakamura M, et al
    Cleft mitral leaflets and severe mitral regurgitation: Testing the limits of percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27980.
    PubMed     Abstract available


  586. PAN W, Pan C, Jilaihawi H, Wei L, et al
    A novel user-friendly transcatheter edge-to-edge mitral valve repair device in a porcine model.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27976.
    PubMed     Abstract available


  587. XU JJ, Song Y, Jiang P, Gao Z, et al
    Effect of prior stroke on long-term outcomes of percutaneous coronary interventions in Chinese patients: A large single-center study.
    Catheter Cardiovasc Interv. 2018 Nov 13. doi: 10.1002/ccd.27705.
    PubMed     Abstract available


  588. GE J, Li J, Dong B, Ning X, et al
    Determinants of angiographic thrombus burden and impact of thrombus aspiration on outcome in young patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Nov 12. doi: 10.1002/ccd.27944.
    PubMed     Abstract available


  589. HABIB N, Mahmoodi BK, Suttorp MJ, Kelder JC, et al
    Long-term results of carotid stenting and risk factors in patients with severe carotid artery stenosis undergoing subsequent cardiac surgery.
    Catheter Cardiovasc Interv. 2018 Nov 9. doi: 10.1002/ccd.27947.
    PubMed     Abstract available


  590. SPINA R, Khalique O, Kodali S, Bapat VN, et al
    Urgent transcatheter aortic valve replacement for severe acute aortic regurgitation following open mitral valve surgery.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27954.
    PubMed     Abstract available


  591. ANDO T, Adegbala O, Villablanca PA, Briasoulis A, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in non-teaching hospitals.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27968.
    PubMed     Abstract available


  592. BUTTER C, Kaneko H, Tambor G, Hara M, et al
    Clinical utility of intraprocedural three-dimensional integrated image guided transcatheter aortic valve implantation using novel automated computed tomography software: A single-center preliminary experience.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27920.
    PubMed     Abstract available


  593. DOWLING C, Firoozi S, Doyle N, Blackman DJ, et al
    Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2018 Nov 5. doi: 10.1002/ccd.27934.
    PubMed     Abstract available


  594. KUMAR A, Block PC
    Paravalvular leak after transcatheter aortic valve replacement: Avoid it or treat it if you can!
    Catheter Cardiovasc Interv. 2018;92:981-982.
    PubMed     Abstract available


    October 2018
  595. USKELA S, Karkkainen JM, Eranen J, Siljander A, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950.
    PubMed     Abstract available


  596. MORRICAL BD, Dearani JA, Cabalka AK
    Melody valve in mitral position: Complete fracture causing acute mitral stenosis in a child.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27683.
    PubMed     Abstract available


  597. ADJEDJ J, Picard F, Mogi S, Iwasaki K, et al
    In vitro flow and optical coherence tomography comparison of two bailout techniques after failed provisional stenting for bifurcation percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Oct 23. doi: 10.1002/ccd.27718.
    PubMed     Abstract available


  598. THONGHONG T, Bieliauskas G, De Backer O, Sondergaard L, et al
    Economical cost of percutaneous vascular closure with ProGlide and Prostar XL following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27697.
    PubMed    


  599. AZZALINI L, Uretsky B, Brilakis ES, Colombo A, et al
    Contrast modulation in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27869.
    PubMed     Abstract available


  600. PINEDA AM, Kevin Harrison J, Kleiman NS, Reardon MJ, et al
    Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 20. doi: 10.1002/ccd.27928.
    PubMed     Abstract available


  601. SPIEKER M, Hellhammer K, Wiora J, Klose S, et al
    Prognostic value of impaired hepato-renal function assessed by the MELD-XI score in patients undergoing percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Oct 17. doi: 10.1002/ccd.27906.
    PubMed     Abstract available


  602. LI J, Patel SM, Nadeem F, Thakker P, et al
    Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27894.
    PubMed     Abstract available


  603. KUMAR A, Sato K, Banerjee K, Narayanswami J, et al
    Hemodynamic durability of transcatheter aortic valves using the updated Valve Academic Research Consortium-2 criteria.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27927.
    PubMed     Abstract available


  604. MISUMIDA N, Pagath M, Ogunbayo GO, Wilson RE, et al
    Characteristics of and current practice patterns of pacing for high-degree atrioventricular block after transcatheter aortic valve implantation in comparison to surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27915.
    PubMed     Abstract available


  605. NELSON BC, Chadderdon S, Song H, Zahr FE, et al
    Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27721.
    PubMed     Abstract available


  606. WELT FGP, Klein LW, Tamis-Holland J, Blankenship J, et al
    Views of Appropriate Use Criteria for catheterization and percutaneous coronary revascularization by practicing interventional cardiologists: Results of a survey of American College of Cardiology Interventional Section members.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27931.
    PubMed     Abstract available


  607. STAHLI BE, Wischnewsky MB, Jakob P, Klingenberg R, et al
    Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography.
    Catheter Cardiovasc Interv. 2018 Oct 5. doi: 10.1002/ccd.27712.
    PubMed     Abstract available


  608. FELDMANN K, Cami E, Safian RD
    Planning percutaneous coronary interventions using computed tomography angiography and fractional flow reserve-derived from computed tomography: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Oct 4. doi: 10.1002/ccd.27817.
    PubMed     Abstract available


  609. CASE BC, Geiser KM, Torguson R, Pichard AD, et al
    Comparison of coronary revascularization appropriateness for non-acute coronary syndrome cases under the 2017 update vs the 2012 appropriate use criteria.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27895.
    PubMed     Abstract available


  610. BUCHANAN KD, Rogers T, Steinvil A, Koifman E, et al
    Role of contractile reserve as a predictor of mortality in low-flow, low-gradient severe aortic stenosis following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27914.
    PubMed     Abstract available


    September 2018
  611. RAWASIA WF, Khan MS, Usman MS, Siddiqi TJ, et al
    Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27840.
    PubMed     Abstract available


  612. BONIN M, Guerin P, Olive JM, Jordana F, et al
    Standardized bench test evaluation of coronary stents: Biomechanical characteristics.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27912.
    PubMed     Abstract available


  613. MORI M, Bin Mahmood SU, Geirsson A, Yun JJ, et al
    Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27855.
    PubMed     Abstract available


  614. SAITO Y, Kitahara H, Okuya Y, Nakayama T, et al
    Novel predictor of target vessel revascularization after coronary stent implantation: Intraluminal intensity of blood speckle on intravascular ultrasound.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27859.
    PubMed     Abstract available


  615. ALQAHTANI F, Ziada K, Rihal CS, Alkhouli M, et al
    Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery.
    Catheter Cardiovasc Interv. 2018 Sep 30:e27874. doi: 10.1002/ccd.27874.
    PubMed     Abstract available


  616. EDRIS A, Bartel T, Tuzcu EM, Suri RM, et al
    Alcohol septal ablation for outflow tract obstruction after transcatheter aortic and mitral valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27723.
    PubMed     Abstract available


  617. KESSLER M, Seeger J, Wohrle J, Rottbauer W, et al
    Intra-aortic balloon counterpulsation pump in heart failure patients during MitraClip implantation-A propensity-score matched analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27717.
    PubMed     Abstract available


  618. SHAH R, Jovin IS, Chaudhry A, Haji SA, et al
    Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27828.
    PubMed     Abstract available


  619. DENEGRI A, Mehran R, Holy E, Taramasso M, et al
    Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome
    Catheter Cardiovasc Interv. 2018 Sep 30:e27806. doi: 10.1002/ccd.27806.
    PubMed     Abstract available


  620. MADUKAUWA-DAVID ID, Midha PA, Sharma R, McLain K, et al
    Characterization of aortic root geometry in transcatheter aortic valve replacement patients.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27805.
    PubMed     Abstract available


  621. BAVARIA JE, Tommaso CL, Brindis RG, Carroll JD, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27811.
    PubMed    


  622. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
    Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
    PubMed     Abstract available


  623. GARCIA S, Mbai M, Kelly R, Bertog S, et al
    Simultaneous transfemoral transcatheter aortic valve replacement and trans-septal mitral valve-in-ring implantation after partial laceration of an Alfieri stitch.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27875.
    PubMed     Abstract available


  624. KIMURA T, Nishibori Y, Miki K, Maruyama T, et al
    Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27787.
    PubMed     Abstract available


  625. PIAYDA K, Hellhammer K, Veulemans V, Zeus T, et al
    Valvuloplasty balloon entrapment in a self-expanding aortic valve stent frame after inadvertent wire passage through the outflow struts.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27858.
    PubMed     Abstract available


  626. LAZKANI M, Sawant AC, Taase A, Khan S, et al
    Left atrial hemodynamics and left ventricular remodeling -predictors of outcomes after Transcatheter mitral valve repair with the MitraClip device.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27804. doi: 10.1002/ccd.27804.
    PubMed     Abstract available


  627. KUME T, Yamada R, Koyama T, Tamada T, et al
    Coronary bifurcation bench test using multimodality imaging: Impact of stent strut link location on stent deformity and jailed side-branch orifices during re-proximal optimizing technique.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27719.
    PubMed     Abstract available


  628. RAPHAEL CE, Malouf JF, Maor E, Panaich SS, et al
    A hybrid technique for treatment of commissural primary mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27904.
    PubMed     Abstract available


  629. HERNANDEZ-ENRIQUEZ M, Regueiro A, Romaguera R, Andrea R, et al
    Thrombocytopenia after transcatheter aortic valve implantation. A comparison between balloon-expandable and self-expanding valves.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27907.
    PubMed     Abstract available


  630. DADU RT, Xu J, Rehman H, von Ballmoos MW, et al
    Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27829.
    PubMed     Abstract available


  631. SHAUKAT A, Mooney M, Burke MN, Brilakis ES, et al
    Use of chronic total occlusion percutaneous coronary intervention techniques for treating acute vessel closure.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27868.
    PubMed     Abstract available


  632. RASHID HN, Nasis A, Gooley RP, Cameron JD, et al
    The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27702.
    PubMed     Abstract available


  633. OKUMURA H, Hayashi H, Harada M, Mikuri M, et al
    Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27836.
    PubMed     Abstract available


  634. BOI A, Sanna F, Rossi A, Loi B, et al
    Acute myocardial infarction secondary to blunt chest trauma in motorcycle accident: A rare combination where percutaneous coronary intervention and intravascular imaging optimization are needed.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27725.
    PubMed     Abstract available


  635. VAN MOURIK MS, Janmaat YC, van Kesteren F, Vendrik J, et al
    CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27823.
    PubMed     Abstract available


  636. BUTERA G, Mansour NB, De Marco F
    Emergency trans-catheter coronary intervention for left main compression secondary to pulmonary hypertension in a 4-year-old child.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27796.
    PubMed     Abstract available


  637. RAFIQ A, Chutani S, Krim NR
    Coronary intervention and arteria lusoria-Not simple as it may seem.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27803.
    PubMed     Abstract available


  638. BRUGALETTA S, Cequier A, Alfonso F, Iniguez A, et al
    MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27825.
    PubMed     Abstract available


  639. BRAUN D, Nabauer M, Massberg S, Hausleiter J, et al
    One-stop shop: Simultaneous direct mitral annuloplasty and percutaneous mitral edge-to-edge repair in a patient with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27848.
    PubMed     Abstract available


    August 2018
  640. GURM HS, Seth M, Dixon SR, Michael Grossman P, et al
    Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27819.
    PubMed     Abstract available


  641. AZIZ M, Simonato M, Webb JG, Abdel-Wahab M, et al
    Mortality prediction after transcatheter treatment of failed bioprosthetic aortic valves utilizing various international scoring systems: Insights from the Valve-in-Valve International Data (VIVID).
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27714.
    PubMed     Abstract available


  642. KHAN JM, Lederman RJ
    Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2018;92:388-389.
    PubMed    


  643. CHATTERJEE A, Hillegass WB
    Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
    Catheter Cardiovasc Interv. 2018;92:431-432.
    PubMed    


    July 2018
  644. TAM DY, Vo TX, Wijeysundera HC, Dvir D, et al
    Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 19. doi: 10.1002/ccd.27686.
    PubMed     Abstract available


  645. CHEN GC, Lu XM, Song YM, Gyawail L, et al
    A 3-year experience of a simple, novel technique for accurate ostial/non-ostial coronary stenting: The buddy balloon anchor stent technique.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27667.
    PubMed     Abstract available


  646. ROGERS T, Gai J, Torguson R, Okubagzi PG, et al
    Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27668.
    PubMed     Abstract available


  647. SMILOWITZ NR, Mohananey D, Razzouk L, Weisz G, et al
    Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27673.
    PubMed     Abstract available


  648. NOAMAN S, Goh CY, Vogrin S, Brennan AL, et al
    Comparison of short-term clinical outcomes of proximal versus nonproximal lesion location in patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction: The PROXIMITI study.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27665.
    PubMed     Abstract available


  649. WUSTROW I, Sarafoff N, Haller B, Rossner L, et al
    Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27678.
    PubMed     Abstract available


  650. RILEY RF, McCabe JM, Kalra S, Lazkani M, et al
    Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27679.
    PubMed     Abstract available


  651. UESHIMA D, Nai Fovino L, Mojoli M, Napodano M, et al
    The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27681.
    PubMed     Abstract available


  652. MAKKI N, Ghao X, Whitson B, Shreenivas S, et al
    Slope of left ventricular filling as an index of valvular and paravalvular regurgitation in native and prosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27684.
    PubMed     Abstract available


  653. DAMLUJI AA, Murman M, Byun S, Moscucci M, et al
    Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
    Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27690.
    PubMed     Abstract available


  654. SHLOFMITZ E, Jeremias A
    Precision percutaneous coronary intervention: Is optical coherence tomography co-registration the future?
    Catheter Cardiovasc Interv. 2018;92:38-39.
    PubMed     Abstract available


    June 2018
  655. BLOCK PC
    Transcatheter treatment of aortic regurgitation: Still enigmatic.
    Catheter Cardiovasc Interv. 2018;91:1352-1353.
    PubMed     Abstract available


    May 2018
  656. HACHINOHE D, Latib A, Montorfano M, Colombo A, et al
    Transcatheter mitral valve implantation in rigid mitral annuloplasty rings: Potential differences between complete and incomplete rings.
    Catheter Cardiovasc Interv. 2018 May 18. doi: 10.1002/ccd.27658.
    PubMed     Abstract available


  657. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
    Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
    PubMed    


  658. JACKSON M, Austin D, Kwok CS, Rashid M, et al
    The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27642.
    PubMed     Abstract available


  659. TAMEZ H, Genereux P, Yeh RW, Amin AP, et al
    Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27638.
    PubMed     Abstract available


    April 2018
  660. SETO AH, Shroff A, Abu-Fadel M, Blankenship JC, et al
    Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions.
    Catheter Cardiovasc Interv. 2018 Apr 24. doi: 10.1002/ccd.27637.
    PubMed     Abstract available


  661. VILLABLANCA PA, Mohananey D, Ramakrishna H
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Apr 16. doi: 10.1002/ccd.27639.
    PubMed    


  662. DE BACKER O, Sondergaard L
    TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions.
    Catheter Cardiovasc Interv. 2018;91:984-985.
    PubMed     Abstract available


  663. KRISHNAN SK, Dean LS
    Looking for the bare necessities.
    Catheter Cardiovasc Interv. 2018;91:956-957.
    PubMed     Abstract available


  664. BURZOTTA F, Trani C
    TAVR technique tries to go higher than bicuspid valve hurdles.
    Catheter Cardiovasc Interv. 2018;91:995-996.
    PubMed     Abstract available


  665. TURI ZG
    The under-appreciated and still under-investigated consequences of "supersized" access and closure.
    Catheter Cardiovasc Interv. 2018;91:945-946.
    PubMed     Abstract available


    March 2018
  666. NDREPEPA G, Kastrati A
    Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
    PubMed    


  667. KINDYA B, Ouzan E, Lerakis S, Gonen E, et al
    Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27607.
    PubMed     Abstract available


  668. HONDA Y, Yamawaki M, Araki M, Tada N, et al
    Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27596.
    PubMed     Abstract available


  669. YE J, Lee AJ, Blanke P, Webb J, et al
    The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27604.
    PubMed     Abstract available


  670. DE PALMA R, Settergren M, Ruck A, Linder R, et al
    Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27595.
    PubMed     Abstract available


  671. GOINS AE, Rayson R, Caughey MC, Sola M, et al
    Correlation of infarct size with invasive hemodynamics in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27625.
    PubMed     Abstract available


  672. MOHDNAZRI SR, Karamasis GV, Al-Janabi F, Cook CM, et al
    The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO.
    Catheter Cardiovasc Interv. 2018 Mar 22. doi: 10.1002/ccd.27587.
    PubMed     Abstract available


  673. TAKAHASHI M, Badenco N, Monteau J, Gandjbakhch E, et al
    Impact of pacemaker mode in patients with atrioventricular conduction disturbance after trans-catheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Mar 14. doi: 10.1002/ccd.27594.
    PubMed     Abstract available


  674. EITAN A, Witt J, Stripling J, Haselbach T, et al
    Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27588.
    PubMed     Abstract available


  675. ABDELGHANI M, de Winter RJ, Miyazaki Y, Modolo R, et al
    Determinants of success and hemodynamic impact of balloon postdilatation of self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27538.
    PubMed     Abstract available


  676. NIIDA T, Murai T, Yonetsu T, Kanaji Y, et al
    Coronary physiological assessment combining fractional flow reserve and index of microcirculatory resistance in patients undergoing elective percutaneous coronary intervention with grey zone fractional flow reserve.
    Catheter Cardiovasc Interv. 2018 Mar 8. doi: 10.1002/ccd.27570.
    PubMed     Abstract available


  677. ANANTHAKRISHNA R, Kristanto W, Liu L, Chan SP, et al
    Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27577.
    PubMed     Abstract available


  678. GOLDSWEIG AM, Wang Y, Forrest JK, Cleman MW, et al
    Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27576.
    PubMed     Abstract available


  679. XIE R, Hillegass WB
    Long-term survival prospects of patients undergoing percutaneous coronary intervention: Envisioning the future.
    Catheter Cardiovasc Interv. 2018;91:696.
    PubMed     Abstract available


  680. TAJTI P, Karmpaliotis D, Alaswad K, Toma C, et al
    Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry.
    Catheter Cardiovasc Interv. 2018;91:657-666.
    PubMed     Abstract available


  681. TAKAGI H, Ando T, Umemoto T
    Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Catheter Cardiovasc Interv. 2018;91:697-709.
    PubMed     Abstract available


  682. MIZOTE I, Schirmer J, Schafer U
    A case of successful Mitraclip implantation in a patient having a large coaptation gap under extracorporeal membrane oxygenation (ECMO).
    Catheter Cardiovasc Interv. 2018;91:827-830.
    PubMed     Abstract available


    February 2018
  683. DAUTOV R, Ybarra LF, Nguyen CM, Gibrat C, et al
    Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27545.
    PubMed     Abstract available


  684. SARAF S, Cockburn J, Alsanjari O, Hildick-Smith D, et al
    Transcatheter aortic valve implantation via the superficial femoral artery: An underused access route?
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27544.
    PubMed     Abstract available


  685. AZARRAFIY R, Albuquerque FN, Carrillo RG, Cohen MG, et al
    Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27546.
    PubMed     Abstract available


  686. HIOKI H, Watanabe Y, Kozuma K, Yamamoto M, et al
    Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27547.
    PubMed     Abstract available


  687. MURAI T, Yonetsu T, Kanaji Y, Usui E, et al
    Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2018 Feb 15. doi: 10.1002/ccd.27529.
    PubMed     Abstract available


  688. BENSON L
    PPVI in children under 20 kilograms: A quid pro quo?
    Catheter Cardiovasc Interv. 2018;91:495-496.
    PubMed     Abstract available


  689. MARTIN MH, Shahanavaz S, Peng LF, Asnes JD, et al
    Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg.
    Catheter Cardiovasc Interv. 2018;91:485-494.
    PubMed     Abstract available


  690. GASPARINI GL, Oreglia JA, Reimers B
    Self-apposing stent-assisted coil embolization for the treatment of coronary artery aneurysm.
    Catheter Cardiovasc Interv. 2018;91:470-474.
    PubMed     Abstract available


  691. WALDO SW, O'Donnell CI, Prouse A, Plomondon ME, et al
    Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.
    Catheter Cardiovasc Interv. 2018;91:425-433.
    PubMed     Abstract available


  692. ADJEDJ J, Toth GG, Pellicano M, Wijns W, et al
    Reversed single string technique for coronary bifurcation stenting-First report of case demonstrations in vitro.
    Catheter Cardiovasc Interv. 2018;91:396-401.
    PubMed     Abstract available


  693. VAN BOMMEL RJ, Lemmert ME, van Mieghem NM, van Geuns RJ, et al
    Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.
    Catheter Cardiovasc Interv. 2018;91:E21-E28.
    PubMed     Abstract available


  694. CAMPOS CM, Caixeta A, Franken M, Bartorelli AL, et al
    Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND an
    Catheter Cardiovasc Interv. 2018;91:387-395.
    PubMed     Abstract available


  695. GASIOR P, Cheng Y, Estrada EA, Jenn McGregor, et al
    Novel ultrahigh molecular weight amorphous PLLA bioresorbable coronary scaffold upsized up to 0.8 mm beyond nominal diameter: An OCT and histopathology study in porcine coronary artery model.
    Catheter Cardiovasc Interv. 2018;91:378-386.
    PubMed     Abstract available


  696. BAILEY SR
    Catheterization and Cardiovascular Interventions CIT Special Issue: Editor In Chief Editorial.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed    


  697. MEHRAN R
    The History of Clinical Research Workshop at CIT: A Ten Year Perspective.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed    


  698. ZIVELONGHI C, van Kuijk JP, Nijenhuis V, Poletti E, et al
    First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27539.
    PubMed     Abstract available


  699. MCNEICE AH, Brooks M, Hanratty CG, Stevenson M, et al
    A retrospective study of radiation dose measurements comparing different cath lab X-ray systems in a sample population of patients undergoing percutaneous coronary intervention for chronic total occlusions.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27541.
    PubMed     Abstract available


  700. SAWANT AC, Bhardwaj A, Banerjee K, Jobanputra Y, et al
    Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27525.
    PubMed     Abstract available


  701. FACCINI A, Butera G
    Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27527.
    PubMed     Abstract available


  702. LIU X, He Y, Zhu Q, Gao F, et al
    Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2018 Feb 5. doi: 10.1002/ccd.27467.
    PubMed     Abstract available


  703. TAKAGI H, Mitta S, Ando T
    Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27521.
    PubMed     Abstract available


  704. WITBERG G, Lador A, Yahav D, Kornowski R, et al
    Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27518.
    PubMed     Abstract available


  705. HEUSER RR
    Perforations and how to manage: The coronary interventionalist and peripheral interventionalist working together for a solution.
    Catheter Cardiovasc Interv. 2018;91:308-309.
    PubMed     Abstract available


  706. PLITT A, Dangas G
    Cardiac enzyme elevation after coronary revascularization.
    Catheter Cardiovasc Interv. 2018;91:224-225.
    PubMed     Abstract available


  707. MISUMIDA N, Moliterno DJ
    Hybrid coronary revascularization: Time for a new comparator?
    Catheter Cardiovasc Interv. 2018;91:213-214.
    PubMed     Abstract available


  708. TAN C, Dean LS
    Conscious sedation for TAVR: A wave of the future?
    Catheter Cardiovasc Interv. 2018;91:343-344.
    PubMed     Abstract available


  709. DI MARIO C, Sorini Dini C
    Maximal efficiency is required to minimize complications and hospital stay after TAVR.
    Catheter Cardiovasc Interv. 2018;91:354-355.
    PubMed     Abstract available


  710. SCHNEIDER HE, Gravenhorst V, Paul T, Jacobshagen C, et al
    Insufficiency of a Damus-Kaye-Stansel anastomosis in a Fontan patient: Transfemoral implantation of an Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2018;91:292-295.
    PubMed     Abstract available


  711. LLURI G, Levi DS, Miller E, Hageman A, et al
    Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2018;91:277-284.
    PubMed     Abstract available


  712. MCGARVEY M, Ali O, Iqbal MB, Ilsley C, et al
    A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:234-241.
    PubMed     Abstract available


  713. SARDAR P, Kundu A, Bischoff M, Chatterjee S, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis.
    Catheter Cardiovasc Interv. 2018;91:203-212.
    PubMed     Abstract available


    January 2018
  714. LIU S, Song C, Zhao Y, Zhu C, et al
    The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Jan 25. doi: 10.1002/ccd.27498.
    PubMed     Abstract available


  715. BADRI M, Shapiro T, Wang Y, Minges KE, et al
    Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27490.
    PubMed     Abstract available


  716. EL SABBAGH A, Eleid MF, Matsumoto JM, Anavekar NS, et al
    Three-dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27488.
    PubMed     Abstract available


  717. SCHAFER U, Kalbacher D, Voigtlander L, Conradi L, et al
    First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27466.
    PubMed     Abstract available


  718. TSURUTA H, Hayashida K, Yashima F, Yanagisawa R, et al
    Incidence, predictors, and midterm clinical outcomes of left ventricular obstruction after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27508.
    PubMed     Abstract available


  719. DONG H, Che W, Jiang X, Peng M, et al
    Carotid artery stenting followed by open heart surgery in 323 patients: One-year results and influencing factors.
    Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27486.
    PubMed     Abstract available


  720. KAGASE A, Yamamoto M, Shimura T, Kodama A, et al
    Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.
    Catheter Cardiovasc Interv. 2018 Jan 11. doi: 10.1002/ccd.27483.
    PubMed     Abstract available


  721. GARCIA S, Kelly R, Mbai M, Gurevich S, et al
    Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Catheter Cardiovasc Interv. 2018 Jan 9. doi: 10.1002/ccd.27478.
    PubMed     Abstract available


  722. ALASTI M, Rashid H, Rangasamy K, Kotschet E, et al
    Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27463.
    PubMed     Abstract available


  723. MALIK SA, Brilakis ES, Pompili V, Chatzizisis YS, et al
    Lost and found: Coronary stent retrieval and review of literature.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27464.
    PubMed     Abstract available


  724. IVERSON A, Stanberry L, Garberich R, Antos A, et al
    Impact of sleep deprivation on the outcomes of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27471.
    PubMed    


  725. AMAT-SANTOS IJ, Rojas P, Gutierrez H, Vera S, et al
    Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27485.
    PubMed     Abstract available


  726. ROGERS T, Lederman RJ
    Percutaneous transaxillary access for TAVR: Another opportunity to stay out of the chest.
    Catheter Cardiovasc Interv. 2018;91:157-158.
    PubMed     Abstract available


  727. AUBERSON D, Gray W
    Good enough...isn't.
    Catheter Cardiovasc Interv. 2018;91:148-149.
    PubMed     Abstract available


  728. VO MN, Brilakis ES, Grantham JA
    Novel use of cutting balloon to treat subintimal hematomas during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:53-56.
    PubMed     Abstract available


  729. SHAHANAVAZ S, Rockefeller T, Nicolas R, Balzer D, et al
    Fracturing a dysfunctional Edwards Perimount bioprosthetic valve to facilitate percutaneous valve-in-valve placement of SAPIEN 3 valve with modified delivery system.
    Catheter Cardiovasc Interv. 2018;91:81-85.
    PubMed     Abstract available


  730. BOUDJEMLINE Y
    A new one-step procedure for pulmonary valve implantation of the melody valve: Simultaneous prestenting and valve implantation.
    Catheter Cardiovasc Interv. 2018;91:64-70.
    PubMed     Abstract available


  731. GASPARINI GL, Oreglia JA, Garbo R
    The trap and occlude technique for retrograde wire externalization during chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2018;91:57-63.
    PubMed     Abstract available


  732. CAPRETTI G, Carlino M, Colombo A, Azzalini L, et al
    Rotational atherectomy in the subadventitial space to allow safe and successful chronic total occlusion recanalization: Pushing the limit further.
    Catheter Cardiovasc Interv. 2018;91:47-52.
    PubMed     Abstract available


  733. GOLESKI PJ, Reisman M, Don CW
    Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018;91:165-168.
    PubMed     Abstract available


  734. NERLA R, Cremonesi A, Castriota F
    Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018;91:169-174.
    PubMed     Abstract available


    December 2017
  735. GOLDSWEIG AM, Kennedy KF, Kolte D, Abbott JD, et al
    Predictors of patient radiation exposure during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27452.
    PubMed     Abstract available


  736. KIM JH, Kim BK, Kim S, Ahn CM, et al
    Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
    PubMed     Abstract available


  737. WANG DD, Eng MH, Greenbaum AB, Myers E, et al
    Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27447.
    PubMed     Abstract available


  738. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
    Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
    PubMed     Abstract available


  739. RASHID HN, McCormick LM, Talman AH, Ihdayhid AR, et al
    Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Catheter Cardiovasc Interv. 2017 Dec 6. doi: 10.1002/ccd.27378.
    PubMed     Abstract available


  740. SHATILA W, Krajcer Z
    A cardiologist's nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication.
    Catheter Cardiovasc Interv. 2017;90:1198-1199.
    PubMed     Abstract available


    November 2017
  741. DANIELS DV, Banerjee S, Alaswad K, Doing AH, et al
    Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
    Catheter Cardiovasc Interv. 2017 Nov 29. doi: 10.1002/ccd.26501.
    PubMed     Abstract available


  742. ALKHALIL A, Golbari S, Song D, Lamba H, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27433.
    PubMed     Abstract available


  743. SILASCHI M, Conradi L, Wendler O, Schlingloff F, et al
    The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27370.
    PubMed     Abstract available


  744. THEUERLE J, Yudi MB, Farouque O, Andrianopoulos N, et al
    Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era.
    Catheter Cardiovasc Interv. 2017 Nov 15. doi: 10.1002/ccd.27411.
    PubMed     Abstract available


  745. MURATA N, Takayama T, Hiro T, Hirayama A, et al
    Balloon pin-hole rupture during percutaneous coronary intervention for recurrent, calcified in-stent restenosis: A case report.
    Catheter Cardiovasc Interv. 2017 Nov 13. doi: 10.1002/ccd.27405.
    PubMed     Abstract available


  746. STAHLI BE, Gebhard C, Gick M, Ferenc M, et al
    Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27412.
    PubMed     Abstract available


  747. FANARI Z, Mahmaljy H, Nandish S, Goswami NJ, et al
    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27410.
    PubMed     Abstract available


  748. SCHOECHLIN S, Brennemann T, Allali A, Ruile P, et al
    Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27384.
    PubMed     Abstract available


    October 2017
  749. BARAN DA, Visveswaran GK, Seliem A, DiVita M, et al
    Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27387.
    PubMed     Abstract available


  750. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
    Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
    PubMed    


  751. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Abstract available


  752. TUMMALA R, Banerjee K, Sankaramangalam K, Mick S, et al
    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27398.
    PubMed     Abstract available


  753. DE PALMA R, Ruck A, Settergren M, Saleh N, et al
    Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27383.
    PubMed     Abstract available


  754. SHOEIB O, Burzotta F, Aurigemma C, Paraggio L, et al
    Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27248.
    PubMed     Abstract available


  755. STEINBERG ZL, Morray BH, Jones TK
    Bicaval Medtronic Melody valve implantation for treatment of severe mitral regurgitation following the Mustard repair: A case report.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27373.
    PubMed     Abstract available


  756. FLUECKIGER P, Singleton M, Vasu S, Zhao D, et al
    Bioprosthetic tricuspid valve thrombosis: Percutaneous PFO closure to improve hypoxia and respiratory failure.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27217.
    PubMed     Abstract available


  757. LEE MS, Gordin JS, Stone GW, Sharma SK, et al
    Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification.
    Catheter Cardiovasc Interv. 2017 Oct 17. doi: 10.1002/ccd.27339.
    PubMed     Abstract available


  758. O'NEILL J, Hogarth AJ, Pearson I, Law H, et al
    Transcoronary pacing to assess myocardial viability prior to percutaneous coronary intervention: Pilot study to assess feasibility.
    Catheter Cardiovasc Interv. 2017 Oct 16. doi: 10.1002/ccd.27349.
    PubMed     Abstract available


  759. LANDES U, Bental T, Levi A, Assali A, et al
    Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: Insights from 18,641 procedures performed over 12-year period.
    Catheter Cardiovasc Interv. 2017 Oct 13. doi: 10.1002/ccd.27375.
    PubMed     Abstract available


  760. DRAFTS BC, Choi CH, Sangal K, Cammarata MW, et al
    Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27377.
    PubMed     Abstract available


  761. LIANG M, Yang S, Fu N, Lu C, et al
    Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27353.
    PubMed     Abstract available


  762. RUPARELIA N, Cao J, Newton JD, Wilson N, et al
    Paravalvular leak closure under intracardiac echocardiographic guidance.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27318.
    PubMed     Abstract available


  763. ANDO T, Akintoye E, Telila T, Briasouolis A, et al
    Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Catheter Cardiovasc Interv. 2017 Oct 9. doi: 10.1002/ccd.27362.
    PubMed     Abstract available


  764. HTUN WW, Grines C, Schreiber T
    Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27346.
    PubMed     Abstract available


  765. CARRERAS ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, et al
    Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27347.
    PubMed     Abstract available


  766. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Abstract available


  767. ENEZATE T, Omran J, Al-Dadah AS, Alpert M, et al
    Fractional flow reserve versus angiography guided percutaneous coronary intervention: An updated systematic review.
    Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27302.
    PubMed     Abstract available


  768. FRANKEN M, Lemos PA
    Treating of aortic valve stenosis in real-life: A multifaceted decision-making challenge.
    Catheter Cardiovasc Interv. 2017;90:671-672.
    PubMed     Abstract available


    September 2017
  769. LIANG FW, Lee JC, Lu TH, Yin WH, et al
    Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27343.
    PubMed     Abstract available


  770. REDDY G, Wang Z, Nishimura RA, Greason KL, et al
    Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27340.
    PubMed     Abstract available


  771. IQBAL MB, Smith RD, Lane R, Patel N, et al
    The prognostic significance of incomplete revascularization and untreated coronary anatomy following percutaneous coronary intervention: An analysis of 6,755 patients with multivessel disease.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27331.
    PubMed     Abstract available


  772. ANDO T, Briasoulis A, Telila T, Afonso L, et al
    Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27336.
    PubMed     Abstract available


  773. AZZALINI L, Candilio L, Carlino M, Colombo A, et al
    Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Sep 25. doi: 10.1002/ccd.27324.
    PubMed     Abstract available


  774. ALQAHTANI F, Aljohani S, Almustafa A, Alhijji M, et al
    Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Sep 23. doi: 10.1002/ccd.27257.
    PubMed     Abstract available


  775. DREXEL T, Helmer G, Garcia S, Raveendran G, et al
    Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27317.
    PubMed     Abstract available


  776. AIT ICHOU J, Larivee N, Eisenberg MJ, Suissa K, et al
    The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27316.
    PubMed     Abstract available


  777. LEISTNER DM, Riedel M, Steinbeck L, Stahli BE, et al
    Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention-impact on physician decision-making: The OPTICO-integration study.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27313.
    PubMed     Abstract available


  778. GIANNINI F, Latib A, Montorfano M, Ruparelia N, et al
    A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27319.
    PubMed     Abstract available


  779. BOEHNEL C, Rickli H, Graf L, Maeder MT, et al
    Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27255.
    PubMed     Abstract available


  780. VAN GILS L, Kroon H, Daemen J, Ren C, et al
    Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27323.
    PubMed     Abstract available


  781. SONG Y, Gao Z, Tang X, Ma Y, et al
    Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27321.
    PubMed     Abstract available


  782. YAHAGI K, Torii S, Ladich E, Kutys R, et al
    Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27314.
    PubMed     Abstract available


  783. ANDO T, Takagi H, Briasoulis A, Telila T, et al
    A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions.
    Catheter Cardiovasc Interv. 2017 Sep 1. doi: 10.1002/ccd.27256.
    PubMed     Abstract available


    August 2017
  784. DHOBLE A, Bhise V, Nevah MI, Balan P, et al
    Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Catheter Cardiovasc Interv. 2017 Aug 28. doi: 10.1002/ccd.27232.
    PubMed     Abstract available


  785. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Abstract available


  786. ALKHALIL A, Lamba H, Deo S, Bezerra HG, et al
    Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 24. doi: 10.1002/ccd.27230.
    PubMed     Abstract available


  787. KRISHNAN S, Daniels D, McCabe JM
    Novel bipolar preshaped left ventricular pacing wire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 11. doi: 10.1002/ccd.27244.
    PubMed    


  788. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Abstract available


  789. FELDMAN T, Guerrero M
    Balloon aortic valvuloplasty in the TAVR era: Not so new but definitely improved.
    Catheter Cardiovasc Interv. 2017;90:311-312.
    PubMed     Abstract available


    July 2017
  790. VILLABLANCA PA, Mohananey D, Nikolic K, Bangalore S, et al
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Jul 24. doi: 10.1002/ccd.27207.
    PubMed     Abstract available


  791. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Abstract available


    June 2017
  792. KOEHLE M, Strote JA, Guadagnoli M, Oldemeyer JB, et al
    A novel mechanical mitral valve replacement using Sapien XT.
    Catheter Cardiovasc Interv. 2017 Jun 9. doi: 10.1002/ccd.27149.
    PubMed     Abstract available


  793. CARR SM, Lubbe DF, Huber PR
    Percutaneous transcatheter balloon dilatation and stenting to the inflow cannula stenosis of a left ventricular assist device.
    Catheter Cardiovasc Interv. 2017;89:1219-1223.
    PubMed     Abstract available


  794. CARRERAS ET, Barghash M, Givertz MM, Bhatt DL, et al
    A heart within a heart.
    Catheter Cardiovasc Interv. 2017;89:1239-1241.
    PubMed     Abstract available


  795. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
    Clinical presentation of patients with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2017;89:1149-1154.
    PubMed     Abstract available


  796. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Abstract available


  797. LUNI FK, Riaz H, Khan AR, Riaz T, et al
    Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:1168-1175.
    PubMed     Abstract available


  798. YAHAGI K, Ladich E, Kutys R, Mori H, et al
    Pathology of balloon-expandable transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27160.
    PubMed     Abstract available


  799. EL-SAID HG, Pockett CR, Moore JW
    Percutaneous obliteration of left ventricular cavity to eliminate aortic regurgitation and presumed coronary steal in an infant with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27138.
    PubMed     Abstract available


  800. ORVIN K, Kornowski R
    The problem of delirium following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017;89:1292-1293.
    PubMed     Abstract available


    May 2017
  801. DOERNER J, Kupczyk PA, Wilsing M, Luetkens JA, et al
    Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2017 May 26. doi: 10.1002/ccd.27122.
    PubMed     Abstract available


  802. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Abstract available


  803. TARAMASSO M, Denegri A, Kuwata S, Rickli H, et al
    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27100.
    PubMed     Abstract available


  804. CONDADO JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, et al
    Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26987.
    PubMed     Abstract available


  805. BRUNNER NW, Yue SF, Stub D, Ye J, et al
    The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27107.
    PubMed     Abstract available


  806. SALNA M, Khalique OK, Chiuzan C, Kurlansky P, et al
    Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27120.
    PubMed     Abstract available


  807. OKOH AK, Chauhan D, Kang N, Haik N, et al
    The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27083.
    PubMed     Abstract available


  808. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Abstract available


  809. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Abstract available


    April 2017
  810. AUFFRET V, Regueiro A, Campelo-Parada F, Del Trigo M, et al
    Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 12. doi: 10.1002/ccd.27040.
    PubMed     Abstract available


  811. SARDAR P, Kundu A, Chatterjee S, Feldman DN, et al
    Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 11. doi: 10.1002/ccd.27041.
    PubMed     Abstract available


    March 2017
  812. YOUNG MN, Elmariah S, Kennedy KF, Inglessis I, et al
    Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Catheter Cardiovasc Interv. 2017 Mar 22. doi: 10.1002/ccd.27018.
    PubMed     Abstract available


  813. MEDURI C, Kauten J, Vannan M, Rajagopal V, et al
    First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26983.
    PubMed     Abstract available


  814. KOIFMAN E, Patel N, Weissman G, Kiramijyan S, et al
    Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26960.
    PubMed     Abstract available


  815. MOHAMMAD NIJRES B, Kenny D, Kazmouz S, Hijazi ZM, et al
    Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26996.
    PubMed     Abstract available


  816. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Abstract available


  817. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Abstract available


  818. VEJPONGSA P, Bhise V, Charitakis K, Vernon Anderson H, et al
    Early readmissions after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 2. doi: 10.1002/ccd.26945.
    PubMed     Abstract available


    February 2017
  819. CONDADO JF, Maini A, Leshnower B, Thourani V, et al
    End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017 Feb 17. doi: 10.1002/ccd.26875.
    PubMed     Abstract available


  820. RAKITA V, Lakhter V, Patil P, O'Neill BP, et al
    Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2017 Feb 7. doi: 10.1002/ccd.26931.
    PubMed     Abstract available


  821. CZARNECKI A, Qiu F, Koh M, Prasad TJ, et al
    Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26906.
    PubMed     Abstract available


  822. MONTONE RA, Testa L, Fraccaro C, Montorfano M, et al
    Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26914.
    PubMed     Abstract available


    January 2017
  823. HORN P, Hellhammer K, Minier M, Stenzel MA, et al
    Deep sedation Vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip(R) system.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26884.
    PubMed     Abstract available


  824. ABDELGHANI M, Tateishi H, Miyazaki Y, Cavalcante R, et al
    Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26926.
    PubMed     Abstract available


    December 2016
  825. JATENE T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, et al
    Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26837.
    PubMed     Abstract available


    November 2016
  826. FETTERLY K, Greason K, Mathew V
    Balloon Valvuloplasty to Predict X-ray Projection Angles that are Perpendicular to Cardiovascular Structures: A TAVI Patient Feasibility Study.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26879.
    PubMed     Abstract available


  827. ZAMAN S, McCormick L, Gooley R, Rashid H, et al
    Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve.
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26857.
    PubMed     Abstract available


  828. CONROTTO F, D'Ascenzo F, D'Amico M, Moretti C, et al
    Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: A Meta-analysis.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26839.
    PubMed     Abstract available


  829. LEHNER A, Ulrich S, Happel CM, Fischer M, et al
    Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech(R) PDA occluder.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26856.
    PubMed     Abstract available


    October 2016
  830. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
    Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
    PubMed     Abstract available


  831. LOYALKA P, Nascimbene A, Schechter M, Petrovic M, et al
    Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26723.
    PubMed     Abstract available


  832. LANDES U, Sagie A, Kornowski R
    Transcatheter aortic valve implantation in degenerative sutureless perceval aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26576.
    PubMed     Abstract available


    September 2016
  833. ACHARJI S, Agnihotri A, Carrozza J
    Transcatheter aortic valve replacement in unicuspid aortic valve stenosis (CCI-16-0461).
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26798.
    PubMed     Abstract available


  834. HARPER AR, Dawkins S, Newton JD
    Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26724.
    PubMed     Abstract available


  835. OKUYAMA K, Chakravarty T, Makkar RR
    Percutaneous transapical pseudoaneurysm closure following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Sep 13. doi: 10.1002/ccd.26494.
    PubMed     Abstract available


    August 2016
  836. HUDED CP, Huded JM, Sweis RN, Ricciardi MJ, et al
    The impact of delirium on healthcare utilization and survival after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26776.
    PubMed     Abstract available


  837. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
    Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
    PubMed     Abstract available


  838. ROGGEN M, Dubois C, Gewillig M
    Coronary artery stenting in a patient with progeria.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
    PubMed     Abstract available


  839. AIRHART S, Medvedev I, Dean LS
    Relative prosthesis-patient mismatch after transcatheter aortic valve replacement: The impact of morbid obesity.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26721.
    PubMed     Abstract available


  840. NAKAMURA K, Passeri JJ, Inglessis-Azuaje I
    Percutaneous closure of acute aorto-right ventricular fistula following transcatheter bicuspid aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26705.
    PubMed     Abstract available


  841. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
    Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
    PubMed     Abstract available


  842. FERRERA C, Nombela-Franco L, Garcia E, Jimenez-Quevedo P, et al
    Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26671.
    PubMed     Abstract available


    July 2016
  843. MANOLY I, Hasan R, Brazier A, Farooq V, et al
    Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
    PubMed     Abstract available


  844. STANGER DE, Abdulla AH, Wong FT, Alipour S, et al
    Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis.
    Catheter Cardiovasc Interv. 2016 Jul 9. doi: 10.1002/ccd.26650.
    PubMed     Abstract available


    June 2016
  845. TRAYNOR MM, Greason KL, Nkomo VT, Pochettino A, et al
    Assisted care as a baseline patient risk characteristic affecting the outcome of transcatheter aortic valve insertion.
    Catheter Cardiovasc Interv. 2016 Jun 8. doi: 10.1002/ccd.26580.
    PubMed     Abstract available


    March 2016
  846. CHAN AW, Wong D, Charania J
    Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis Using Lotus Valve System.
    Catheter Cardiovasc Interv. 2016 Mar 31. doi: 10.1002/ccd.26506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: